<PAGE>
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------

                       SECURITIES AND EXCHANGE COMMISSION

                             WASHINGTON, D.C. 20549
                            ------------------------

                                   FORM 10-K
                                ---------------

                                   (MARK ONE)

/X/  ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE
    ACT OF 1934 (NO FEE REQUIRED EFFECTIVE OCTOBER 7, 1996)

                    FOR THE FISCAL YEAR ENDED MARCH 31, 1999

                                       OR

/ /  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
    EXCHANGE ACT OF 1934 (NO FEE REQUIRED)

                 FOR THE TRANSITION PERIOD FROM       TO

                         COMMISSION FILE NUMBER 0-26962

                            A.D.A.M. SOFTWARE, INC.
               (Exact name of Registrant as specified in its charter)

<TABLE>
<S>                                            <C>
                   GEORGIA                                      58-1878070
       (State or other jurisdiction of                       (I.R.S. employer
       incorporation or organization)                       identification no.)
</TABLE>

                             1600 RIVEREDGE PARKWAY
                                   SUITE 800
                             ATLANTA, GEORGIA 30328
                    (Address of Principal Executive Offices)
                                 (770) 980-0888
              (Registrant's telephone number, including area code)
          Securities registered pursuant to Section 12 (b) of the Act:
                                      NONE

          Securities registered pursuant to Section 12 (g) of the Act:

<TABLE>
<S>                                            <C>
             TITLE OF EACH CLASS                 Name of Each Exchange on which Registered
---------------------------------------------  ---------------------------------------------
         Common Stock $.01 par value                               None
</TABLE>

                            ------------------------

    Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports) and (2) has been subject to such
filing requirements for the past 90 days. Yes /X/  No / /

    Indicate by check mark if disclosure of delinquent filers pursuant to Item
405 of Regulation S-K is not contained herein and will not be contained to the
best of the Registrant's knowledge, in definitive proxy or information
statements incorporated by reference in Part III of this Form 10-K or any
amendment to this Form 10-K.  / /

    The aggregate market value of the voting stock held by non-affiliates of the
Registrant was $46,923,841 at June 25, 1999 based on the closing market price of
the Common Stock on such date as reported by the Nasdaq Stock Market's National
Market. As of such date, there were 4,612,307 shares of the Registrant's Common
Stock, par value $.01 per share, outstanding excluding shares held in treasury
by the Registrant.

DOCUMENTS INCORPORATED BY REFERENCE

    None.

--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
<PAGE>
                               TABLE OF CONTENTS

<TABLE>
<CAPTION>
                                                                                                                  PAGE
                                                                                                                  -----
<S>                <C>                                                                                         <C>
PART I
  Item 1.          Business..................................................................................           1
  Item 2.          Properties................................................................................          13
  Item 3.          Legal Proceedings.........................................................................          13
  Item 4.          Submission of Matters to a Vote of Security Holders.......................................          13

PART II
  Item 5.          Market for Registrant's Common Equity and Related Stockholder Matters.....................          14
  Item 6.          Selected Financial Data...................................................................          15
  Item 7.          Management's Discussion and Analysis of Financial Condition and Results of Operations.....          16
  Item 7A.         Quantitative and Qualitative Disclosures About Market Risk................................          16
  Item 8.          Financial Statements and Supplementary Data...............................................          24
  Item 9.          Changes in and Disagreements With Accountants on Accounting and Financial Disclosures.....          24

PART III
  Item 10.         Directors and Executive Officers of the Registrant........................................          25
  Item 11.         Executive Compensation....................................................................          28
  Item 12.         Security Ownership of Certain Beneficial Owners and Management............................          31
  Item 13.         Certain Relationships and Related Transactions............................................          32

PART IV
  Item 14.         Exhibits, Financial Statement Schedules and Reports on Form 8-K...........................          34

SIGNATURES
</TABLE>

                                       i
<PAGE>
PART I

ITEM 1. BUSINESS

GENERAL

    A.D.A.M. Software, Inc., d/b/a adam.com ("adam.com") is a leading developer
of health education content and software technologies, and since January 1999,
we have taken steps to become a leading provider of health, medical and wellness
information online. We have created, published and marketed multimedia software
products, content and Internet-ready applications that provide anatomical,
medical and health-related information for the education, consumer and
professional markets. During the fiscal year ended March 31, 1999 ("fiscal
1999"), adam.com made the strategic decision to focus the majority of its
efforts on the online dissemination of consumer health information, resulting in
the May 1999 launch of www.adam.com, adam.com's consumer health destination (the
"Web site" or "site"). In connection with this redirected strategy, we decided
to discontinue further sales and marketing effort, as well as product update and
upgrade support for certain of our historical products as of April 1, 1999. For
a description of these products, see "--Products--A.D.A.M. CD-ROM Products"
below.

    We operate an Internet-based consumer health destination on the world wide
web that offers health content coupled with a user-friendly interface, powerful
search and retrieval capabilities and a broad array of educational text and
visual images. We believe health information is one of the fastest growing areas
of interest on the Internet. For the year ended July 31, 1998, industry analyst
reports estimated that 17 million adults regularly search online for health
information. Analysts expect this number to grow to approximately 30 million a
year by July 2000. Healthcare is one of the largest segments of the U.S.
economy, with annual expenditures of $1 trillion, including $150 billion spent
by consumers on health-related products and services.

    The site contains information from our vast library of proprietary health
and medical content including: the 4,000 topic adam.com medical encyclopedia, a
web-enabled, hyperlinked collection of articles, photographs and illustrations
on diseases, symptoms, injuries, tests, nutrition and other preventive health
topics; the adam.com visual image database with thousands of static medical
illustrations, full dissectible male and female bodies, 3-D models, interactive
animations and broadcast quality video; and Iliad, an expert knowledge base that
calculates differential diagnosis options for medical conditions. These content
assets have taken us more than 20 years to develop, and we believe that
collectively they represent the single largest collection of proprietary medical
content anywhere in the world.

    In the past six months, adam.com has established a string of important
strategic relationships that we believe significantly strengthen our
distribution capabilities including relationships with two leading Internet
portal companies, Yahoo! and Excite, CNN Network Group, and Cox Interactive
Media. In addition, we have signed a definitive merger agreement to acquire "Dr.
Greene's Housecall" which operates www.drgreene.com, an award-winning pediatric
web site, with the acquisition expected to close in July 1999. The acquisition
of drgreene.com is subject to customary closing conditions and there can be no
assurance that it will close in July 1999, or at all. Additionally, we have
formed a relationship with University of California at San Francisco (UCSF)
School of Nursing to provide additional expert medical information at our Web
site.

    Founded in 1990, adam.com historically created visual anatomy and health
information content that was delivered to end-users through a variety of
distribution mediums, including CD-ROM, broadcast, Internet licensing and print.
Those efforts continue today, but are designed to support the growth and
development of our adam.com Web site and business. Adam.com is headquartered in
Atlanta, Georgia, with a significant and expanding operation in San Francisco,
California.

                                       1
<PAGE>
STRATEGY

    Our strategy is to establish adam.com as a leading brand and provider of
health information education content and make our Web site a leading online
consumer health destination. The key elements of our strategy are:

    - ESTABLISH ADAM.COM AS A MAJOR NEW, UNIQUE MEDIA BRAND RECOGNIZED FOR HIGH
      QUALITY MEDICAL INFORMATION. Our products and content are used regularly
      in homes, schools and healthcare institutions. We believe we can build on
      our established reputation, and distinguish ourselves from our
      competitors, by leveraging 10 years of experience in creating
      award-winning health information, and we intend to create a unique health
      destination that offers proprietary health content, contextual search
      capabilities, engaging discussion communities and unique, rich media
      experiences.

    - LEVERAGE CONTENT OWNERSHIP FOR PROMOTION AND BRANDING OPPORTUNITIES. Our
      ownership of the image database and other health and medical content has
      enabled us to enter into relationships with companies such as Yahoo! that
      display our content and provide a link to our website without charging us
      a fee. Other online health information providers have been required to pay
      substantial amounts to have their content included on portal websites. We
      intend to continue to leverage our content ownership for cost-effective
      promotion and branding opportunities.

    - GENERATE REVENUES FROM ADVERTISING, SPONSORSHIP, CO-BRANDING, PRIVATE
      LABELING AND E-COMMERCE. We believe adam.com is well positioned through
      its distribution alliances and unique proprietary content ownership to
      create an attractive user demographic that appeals to advertisers and
      sponsors who are trying to reach the healthmed retriever market, which is
      composed of persons who search the Web for health related information. The
      healthmed retriever demographic is generally considered an upscale,
      attractive demographic market, well educated with a high degree of
      disposable income. In addition, we intend to offer portions of the site as
      co-branded or private labeling opportunities to hospitals, drug stores,
      physician practice management companies and others as an additional
      revenue source, and to begin to facilitate e-commerce transactions over
      the next few months helping site users find goods and services that assist
      in accomplishing their health objectives.

    - GROW AND EXPAND OUR MANAGEMENT TEAM, CAPITAL BASE AND BUSINESS. We plan to
      hire additional senior management with Internet and health-service-related
      backrounds to lend expert guidance in further developing the site and our
      business. Also, we will actively seek opportunities for strategic
      transactions intended to raise capital to develop our emerging business
      strategy, potentially including the issuance of additional equity or debt
      instruments. In addition, we will continue to evaluate and may enter into
      strategic transactions, including mergers and acquisitions.

THE WEB SITE

    The site includes a broad spectrum of health information aggregated from a
variety of sources, including adam.com's proprietary content. In addition to
broad, comprehensive coverage, the site also features in-depth content in
specific areas of interest to health-conscious consumers. The site indexes all
content types in a hierarchy of health care terminology for easy access, and
provides a high level of integration among the various sources and types of
content.

    The content on adam.com is organized and accessed in multiple ways.
Sophisticated search mechanisms and an easy-to-navigate directory lead users to
the topics of interest. Once the user identifies a topic of interest, the site
organizes the various multimedia content elements within the topic in a "topic
center." A topic center aggregates various content elements and links to related
features on a particular topic, providing users with "in-context" answers to
their health questions.

                                       2
<PAGE>
    The site incorporates the following elements and features to deliver
comprehensive health information:

    - ENCYCLOPEDIA ARTICLES from the adam.com medical encyclopedias supply
      information on diseases, symptoms, injuries, surgeries, tests, nutrition
      and other preventive health topics. The encyclopedias consist of over
      4,000 topics covering over 30 medical specialties written in
      consumer-friendly language. In addition, the articles are extensively
      cross-referenced and are complemented with over 1,400 of adam.com's
      award-winning color photographs and medical illustrations. The articles
      contain information on alternative names/disease synonyms, definition,
      causes, incidence and risk factors, prevention, symptoms, signs and test,
      treatment, expectations (prognosis), complications and when to call a
      health care provider.

    - DRUG INFORMATION features information on drug interactions, drug allergies
      as well as drug education information and answers to questions about
      prescription and over-the-counter medications.

    - NEWS featuring health articles from numerous sources, including Reuters.
      In addition, the site provides an archive of news articles from the past
      two years. The site integrates news articles with other content on a given
      topic.

    - COMMUNITY enables users to interact, exchange information and form real
      relationships with both other users and health care experts. The community
      also includes:

       -  message boards where users read and post messages on a "hosted" area
           of the site organized into conferences and topics,

       -  expert chat where users interact in real-time with health care
           experts,

       -  chat rooms where users communicate in a chat room, enabling them to
           communicate with each other in live, group discussions moderated by
           qualified, active "community leaders."

    - VISUALS to enhance the text content presented. The visuals are linked to
      specific content elements and topic centers. The various types of visual
      that are incorporated into the site are:

       -  medical images including photographs, medical illustrations and
           medical imaging visuals (MRIs, x-rays, sonograms, etc.);

       -  the Health Illustrated series, which focuses on procedures, surgeries,
           tests and self care techniques and presentation of illustrations
           along with text descriptions to help users visualize and understand
           health care treatments, with each series designed to inform the
           consumer about the normal anatomy, indications and procedures; and

       -  Interactive Health Modules which include animations, movies and other
           multimedia content that focus on complicated procedures, pathological
           developments and physiological processes and which may include a
           series of that explains the lungs, the working of the human heart, or
           explain a medical concept or procedure at a consumer level.

THE LIDO (LEGAL INNOVATIONS DELIVERED ONLINE) PROJECT

    LIDO.COM ("LIDO.com") is the first online subscription-based support service
designed for legal professionals involved in tort litigation. The LIDO project
product development began in fiscal 1999 and we expect to significantly increase
development and marketing efforts to achieve a summer, 1999 full launch of the
site. LIDO.com's objectives are to adapt the workflow and aggregate the
components and services involved in medi-legal litigation support. The site will
leverage adam.com's extensive medical legal illustration database.

                                       3
<PAGE>
    LIDO.com will be targeted to the legal services market that includes
litigators, medical experts, nurse consultants, forensic specialists,
paralegals, and continuing legal education trainers. Users will access
LIDO.com's services by paying annual subscription fees transacted through the
site's e-commerce capability.

ADAM.COM CD-ROM PRODUCTS

    We have historically created software products with varying levels of
content, functionality and price for the education, consumer and professional
markets, and we license our content and software technologies to other potential
software developers in the healthcare and health information markets. Our
educational products serve the medical school, undergraduate, allied health
(nursing, physical therapy, occupational therapy, etc.) and K-12 markets,
consumer products serve home computer users, and professional products serve the
healthcare, pharmaceutical, legal and broadcast markets.

    EDUCATION

    For fiscal 1999, sales of products to the education market accounted for
approximately 77.6% of our revenues. We expect this percentage to decrease
significantly during fiscal 2000 as we focus on our Internet strategies.

    A.D.A.M. INTERACTIVE ANATOMY (AIA), our flagship product released in the
first fiscal quarter of 1998, provides an integrated environment for the
teaching and study of human anatomy at the higher education and professional
levels. Powerful tools and search capabilities offer the user access to over
20,000 anatomical structures in six different views. Three-dimensional images
based on the Visible Human data set, cadaver photographs from the Bassett
collection, pinned anatomical images and Slide Show (a built-in curriculum
integration and authoring tool) augment AIA's digital medical illustrations.
Also, one-button Internet access provides solutions for distance learning as
well as offering seamless integration of the Internet and its capabilities.

    A.D.A.M. PRACTICE PRACTICAL ("APP") is a program that simulates gross
anatomy practical exams, complete with pinned atlas images and time limits.
Tests can be customized by region, system or specific course syllabus. APP
combines 15,000 questions with over 500 detailed adam.com illustrations, cadaver
photographs and radiographs.

    A.D.A.M. BENJAMIN/CUMMINGS INTERACTIVE PHYSIOLOGY ("IP") is a series of five
co-developed products between adam.com and Pearson Education ("AWL"), which were
designed for the undergraduate health sciences curriculum and completed during
fiscal 1997. Each module is designed to integrate anatomical structures with
physiological functions. IP uses animation, audio, narration and video to
explain difficult and complicated physiology concepts and processes. Its
organization and self-test features provide the methodology for curriculum
integration. The five modules are described below:

    - CARDIOVASCULAR SYSTEM offers colorful images and informative animations
      that present topics related to heart and blood vessel physiology. Covered
      in this module are: Heart Physiology-Anatomy Review of the Heart,
      Intrinsic Conduction System, Cardiac Action Potential, Cardiac Cycle,
      Cardiac Output Blood Vessel Physiology, Blood Vessel Structure and
      Function, Factors That Affect Blood Pressure, Measuring Blood Pressure and
      Autoregulation and Capillary Dynamics.

    - MUSCULAR SYSTEM uses the detailed illustrations of muscles at gross and
      micro-levels to demonstrate the structure and function of the muscular
      system. Topics covered in the Muscular Module include: Anatomy
      Review-Skeletal Muscle Tissue, The Neuromuscular Junction, Sliding
      Filament Theory, Muscle Metabolism, Contraction of Motor Units and
      Contraction of Whole Muscle.

                                       4
<PAGE>
    - RESPIRATORY SYSTEM offers detailed information at the gross and cellular
      level on this vital system of the body. The module includes: Anatomy
      Review-Respiratory Structures, Pulmonary Ventilation, Gas Exchange, Gas
      Transport and Control of Respiration.

    - NERVOUS SYSTEM, sub-titled "The Neuron: The Action Potential," presents
      in-depth information on Neurons, Resting Membrane Potential and the
      Generation/Propagation of the Action Potential with the Nervous System.
      The module includes: Orientation, Anatomy Review, Ion Channels, Membrane
      Potential and Action Potential.

    - URINARY SYSTEMS details Glomerular Filtraton, Early Filtrate Processing
      and Late Filtrate Processing. The Anatomy Review includes key features of:
      The Nephron, Tubular Segments and Associated Blood Vessels and Renal
      Corpuscle.

    A.D.A.M. AT HOME SERIES--SCHOOL EDITIONS include A.D.A.M. THE INSIDE
STORY--SCHOOL EDITION, NINE MONTH MIRACLE--SCHOOL EDITION and LIFE'S GREATEST
MYSTERIES--SCHOOL EDITION. These products combine the stand-alone A.D.A.M. AT
HOME PRODUCTS with comprehensive teachers' guides to meet the needs of a
classroom setting. A.D.A.M. THE INSIDE STORY--SCHOOL EDITION enables study of
human anatomy and physiology in a middle school biology or life sciences course,
while NINE MONTH MIRACLE--SCHOOL EDITION is designed to supplement the study of
human reproduction at the high school level. The teachers' guides for each
product include student worksheets, ideas for classroom activities, laboratory
exercises, a bibliography of additional learning resources and teacher reference
materials.

    A.D.A.M. STANDARD is a program designed primarily for undergraduate
institutions with health science programs. It is the intermediate-level
application in the A.D.A.M. Scholar Series and provides a thorough overview of
human anatomy. The key features of A.D.A.M. Standard are: (1) approximately 200
layers of anatomy and 18,000 identifiable anatomical structures; (2) scientific
and medical terminology consistent with undergraduate level of study; (3)
anterior, posterior and limited lateral dissectible views of anatomy and a
static medial view; (4) three levels of magnification; (5) histologies,
cross-sections, MRI's, text, overviews and select audio pronunciations; and (6)
interactive systems study that permits the exploration of each system of the
human body. We do not expect this product to generate significant future
revenue, and we ceased committing significant sales, marketing or product
development resources to support it as of April 1, 1999.

    A.D.A.M. ESSENTIALS is designed primarily for high school biology/anatomy
teachers, libraries and introductory/non-major college courses. A.D.A.M.
Essentials incorporates a simplified interface design that enables the user to
explore dissectible anatomy and animations of physiological content in a simple,
easy-to-use manner. The key features of A.D.A.M. essentials include: (1)
approximately 100 layers of anatomy and 4,000 identifiable anatomical
structures; (2) lay and scientific terminology, labeling and an audio
pronunciation guide appropriate for introductory level study; (3) interactive
systems study with 38 animations and text overviews that permits the exploration
of each system of the human body and its related functions; (4) anterior and
posterior dissectible views of anatomy; (5) two levels of magnification; and
(6)interactive puzzles designed to enhance learning comprehension. We do not
expect this product to generate significant future revenue, and we ceased
committing significant sales, marketing or product development resources to
support it as of April 1, 1999.

    PROFESSIONAL

    For fiscal 1999, sales of products to the professional market accounted for
approximately 13.3% of our revenues.

    ILIAD is a medical expert software CD-ROM program used worldwide by health
care clinicians to provide expert diagnostic consultations and patient
simulations. Version 4.5 covers more than 930 diseases and 1500 syndromes and
provides treatment protocols for each including the ICD-9 codes for each
diagnosis. There are 11,900 disease manifestations covering topics in Internal
Medicine, Pediatrics,

                                       5
<PAGE>
Dermatology, Psychiatry, OB/GYN, Peripheral Vascular Diseases and Sleep
Disorders. Iliad acts as an expert consultant that provides a differential
diagnosis, or acts as a second opinion to critique a presumptive diagnosis. The
program can assist in selecting the most appropriate and cost-effective data at
any stage in the patient work up. The program also comes with 90 simulated
patient cases that can be used to test specific diagnostic problem solving
skills.

    ONLINE ENCYCLOPEDIAS:  Our Medical Encyclopedia, Pediatric Encyclopedia, and
Sexually Transmitted Disease Encyclopedia contain thousands of articles
complemented with color photographs and illustrations. These HTML-based,
interactive online encyclopedias cover a full range of topics including
diseases, symptoms, medical tests, surgeries, drugs, nutrition, poisons and
injuries.

    ACTIVEX DISSECTIBLE ANATOMY COMPONENT--This product includes illustrated,
fully dissectible male and female bodies. The product utilizes powerful features
such as Pixel Level Recognition to identify over 24,000 structures. The
component presentation allows the dissectible anatomy to be incorporated into
third party applications, making it possible to integrate A.D.A.M. content into
electronic medical records and other health information systems. This component
was introduced in the fourth quarter of fiscal 1998. We do not expect this
product to generate significant future revenue, and we ceased committing
significant sales, marketing or product development resources to support it as
of April 1, 1999.

    MLI'S WINNING MEDICAL ILLUSTRATIONS is a 5-volume set of CD-ROM discs
containing high-quality anatomical, trauma, and medical-related images and
exhibits for use in settlement brochures, jury education materials and trial
exhibits. Designed primarily for personal injury and medical malpractice
attorneys, the image database includes over 10,000 medical illustrations used in
over 2,500 exhibits and approximately 1,300 cases. We do not expect this product
to generate significant future revenue, and we ceased committing significant
sales, marketing or product development resources to support it as of April 1,
1999.

    CONSUMER

    For fiscal 1999, sales of products to the consumer market accounted for
approximately 5.5% of our revenues.

    A.D.A.M. THE INSIDE STORY 1997 EDITION is a consumer "edutainment" program
designed for family use that provides adam.com anatomy content in an easy-to-use
software application. A.D.A.M. The Inside Story features a "Family Scrapbook" in
which modern-day Adam and Eve characters lead a light-hearted, animated tour
through each system of the body. These characters are given personalities and
provide an entertaining story-line approach to the exploration of human anatomy.
Fifty-two animations, six interactive puzzles, a medical glossary, 3-D content,
the "Quizmeister" testing feature and one-button Internet access provide an
engaging and educational multimedia experience.

    NINE MONTH MIRACLE is a consumer "edutainment" program designed for use by
family members with an interest in pregnancy. Nine Month Miracle contains
animations and video in which modern-day Adam and Eve characters join medical
experts for a month-by-month tour depicting the development of a fetus from
conception through delivery. This product also integrates dramatic intra-uterine
photography by Lennart Nilsson, an informative glossary from the American
College of Obstetricians and Gynecologists and video footage from the Nine
Months documentary to create a unique multimedia experience. Nine Month Miracle
also features "Emily's New Sister," a chapter where cartoon animations allow
younger children to discover the miracle of a new baby through the eyes of a
7-year old character named Emily.

    LIFE'S GREATEST MYSTERIES is a consumer "edutainment" product designed for
use by all members of the family that provides an interactive exploration of the
myths, mysteries and curiosities of the human body. Using detailed animations
and a simple "Q&A" format, a live entertaining character named Bob

                                       6
<PAGE>
Winkle reveals answers to dozens of questions ranging from "What is cancer?" and
"What causes Alzheimer's Disease?" to curiosities such as "What causes
headaches?" and "Why does hair turn gray?" LIFE'S GREATEST MYSTERIES also
includes activities to help reinforce key concepts, a supplemental text
reference section and a glossary of key terms.

    PHYSICIAN'S HOME ASSISTANT and PEDIATRICIAN'S HOME ASSISTANT, are
easy-to-use symptom analysis tools and medical reference guides intent on
creating an informed patient. These products offer extensive disease, nutrition,
surgery, medical record, drug side-effect and interaction databases. These
products were acquired from Mosby in October 1997.

PRODUCT DEVELOPMENT

    We seek to achieve a competitive advantage in the Internet consumer portal
market by developing distribution technologies and a proprietary knowledge base
centered around our vast database of content. We intend to look for
opportunities to purchase existing software and technology where possible and
where it is strategically and economically advantageous to do so. We develop
tools and technologies where we believe such development will provide a
competitive advantage in the marketplace by both extending the reach of our
content and by driving traffic back to our Web site.

    Our knowledge base consists of the medical image database, the adam.com
Online Medical Encyclopedias and other consumer reference materials, and
consumer and medical professional vocabularies. We consider our vast image
database to be "evergreen" in that it does not have a shelf life related to its
relevance for the audiences that it serves. We develop proprietary technologies
and tools for indexing our knowledge base with several goals in mind. First,
abstracting the terminology from the content allows us to broaden the audience
for our content by providing professional and consumer versions of content where
appropriate, and for international audiences where it is strategically and
economically viable. Secondly, the classification and categorization of the
content for different topics, such as General Medical, Pediatric, Women's
Health, and Sexually Transmitted Diseases, allows us to publish different
versions and subsets of our content for use on our own consumer health site, and
in licensing arrangements with strategic partners for use on both the Internet
and for Intranets. These technologies also allow for the rapid production and
deployment of versions of the adam.com Online Medical Encyclopedias with
different strategic purposes. Examples include:

(1) Low-cost versions with no cross references between the over 4,000 articles;

(2) versions designed with configurable references back to our consumer health
    site for increased traffic; and

(3) versions with increased numbers of pages and cross-references designed to
    increase the number of pages viewed and time spent on the subject by the
    given user, both important metrics in the consumer internet space.

    These same technologies also enable us to offer co-branded versions of our
site. We have made a commitment to continue to evolve these highly-scaleable
technologies to continue to augment and aggregate content, and for the
acquisition and deployment of content through partnerships and acquisitions.

    In order to ensure high availability of its content to consumers and
partners, we host our content on highly-scaleable servers provided by Compaq
Computer Corporation hosted at the Santa Clara data center of Exodus
Communications. The architecture is designed to ensure high availability through
the replication of applications and other software services, failure detection
and automatic restart of failed services and applications. We also provide data
redundancy, or data duplicity, through hot-swappable hardware, and ensured
quality of service through load-balancing of Internet traffic.

                                       7
<PAGE>
    The National Institute for Science and Technology (NIST) awarded us a
research grant of $1.2 million to expand the reach of our high bandwidth content
(video and high-quality graphics) over the Internet. We believe that this
technology grant, along with the increasing trend of lower cost bandwidth and
our strategic relationships with broadcast and portal companies represents a
significant opportunity for us in leveraging our position as a content provider
and consumer web site.

SALES, MARKETING AND DISTRIBUTION

    Historically, we employed a wide range of marketing and distribution
strategies in the academic and professional markets to promote brand name
recognition, broaden product distribution and increase market share. In fiscal
1997, we licensed our consumer product line to Mindscape, Inc. for distribution
into the retail market, relieving us of sales, marketing and distribution
responsibilities in the consumer market. During fiscal 1998, we had two
distributors that each accounted for more than 10% of net revenues. In fiscal
1999, we expanded our business strategy to embrace Internet-related
opportunities. We have modified this sales and marketing approach to focus on a
dual track strategy of Web and CD-ROM based products.

    In the education market, we historically marketed our products through both
direct and indirect channels. Product sales were performed by in-house direct
and third party, indirect (distributors and resellers) sales forces. The direct
sales force primarily transacted sales and licensing for targeted educational
institutions and other licensees, while the reseller and distribution network
was designed to target students and consumers. We employed direct telesales
representatives and field sales people, and had a network of value-added
resellers and catalog resellers to sell our institutional products. In addition,
we worked non-exclusively with various educational distributors in addressing
the student market. Sales and marketing activities included advertising, media
relations, direct mailings, distribution of brochures, participation in
educational seminars, campus visits by field sales personnel, telemarketing and
telesales efforts.

    During fiscal 1999, we decided to change the way our CD-ROM based software
was sold and we began transitioning much of the direct sales activity to an
indirect distribution model. During the second quarter of fiscal 1999, we began
downsizing our direct sales and marketing operations, with emphasis placed on
enhancing its distributor/reseller network. We were able to leverage our
developed, strong relationships with leading educational market resellers,
resulting in transition to a 100% indirect sales force by the end of fiscal
1999. As of March 31, 1999 the effect of the transition was a 50% reduction in
sales force, a reassignment of our remaining sales force and an increase in the
percentage of overall indirect sales to 90% of total product sales. We plan to
sell CD-ROM based products to help leverage our Internet strategy. We plan to
offer those products as "premiums", or steeply discounted promotions offered by
third parties. We will earn smaller margins from this approach than we have
historically achieved on our products, but we intend to promote our Web site via
links in the products. As of March 31, 1999, we had entered into one such
premium agreement, and we are actively seeking additional strategic partners to
generate revenue and significant Web site traffic.

    We have increased our licensing activity by licensing our online medical
encyclopedia to other Internet-based companies. As of March 31, 1999, we had
content license agreements with a major portal web site and other well
established consumer health oriented sites, the effect of which was to create
awareness of the adam.com brand and quality of content while generating
additional revenue. Additionally, most adam.com content licensed to other sites
appears with a link back to our own site, generating valuable "traffic" and
opportunity for adam.com to generate additional advertising and/or sponsorship
revenue at our site.

    We expect to sell advertising and sponsorship opportunities, as well as
CD-ROM based and other health related products and services, at our Web site. We
will also leverage other e-commerce and partner-based opportunities as they
present themselves. We currently outsource the majority of our banner
advertising and sponsorship sales to a national firm, and we intend to expand
our own internal

                                       8
<PAGE>
sales operation for co-branding and private label sales. In addition, we intend
to continue to develop strategic alliances that we expect to drive traffic to
the Web site.

    Our marketing efforts are targeted towards creating greater awareness of our
online presence. Our integrated marketing approach includes market research,
online and offline advertising campaigns, as well as end-user promotional
activities such as contests and registration incentives. Media and consumer
research are expected to allow us to refine our targeting and messaging,
evaluate ad placement and develop product enhancements. Internal and external
resources will be used for research, including but not limited to Web tracking,
ad tracking, focus groups, surveys--both online and offline. We plan to launch
advertising campaigns in both online and offline media to include other sites,
newspapers, magazines and radio ads targeted toward the desired
audience-consumers interested in health related information and products.

STRATEGIC ALLIANCES

    We have established a number of important relationships with various
companies that operate in the markets adam.com serves. A summary of our
significant alliances is set forth below:

YAHOO!

    Yahoo!, a leading global internet company, licenses adam.com for its new
Yahoo! health site. The adam.com content is highly branded and each page of our
content on Yahoo offers a link to the adam.com Web site. We believe the Yahoo!
visibility will attract new users to our Web site. Yahoo! has attracted over 60
million users to date. adam.com and Yahoo! have a two-year licensing agreement
that expires in May 2001.

COX INTERACTIVE MEDIA

    Cox Interactive Media ("CIMedia"), a subsidiary of Cox Enterprises, Inc. and
adam.com have an alliance whereby adam.com will be featured on CIMedia's network
of 30 local city web sites. We create specialized health and medical content for
each of the local sites, and the content is co-branded with the Web site name
and adam.com. Through this agreement, adam.com is able to offer its advertisers
local market coverage in addition to the national coverage available through the
Web site.

PEARSON EDUCATION, A SUBSIDIARY OF PEARSON PLC

    AWL is a major publisher for the undergraduate market for science, health
science, nursing and allied health. AWL is one of our shareholders and it has
product development and distribution relationships with us. AWL worked with us
to and co-developed a series of multimedia products, known as A.D.A.M.
BENJAMIN/CUMMINGS INTERACTIVE PHYSIOLOGY, for the undergraduate health science
market. Both companies sell these products, with adam.com focused on the
institutional market and AWL focused on the student market.

CNN NEWSSOURCE, A DIVISION OF CNN

    During fiscal 1998, we signed an agreement with CNN Newssource, a division
of CNN, for distribution of a special compilation of our content into the
broadcast news marketplace. CNN Newssource was granted exclusive domestic rights
to represent our image database to television news broadcasters for use in
enhancing health and medical news coverage. CNN Newssource is responsible for
the sales, marketing and distribution of our content into the local and national
broadcast news market. CNN Networks, including CNN, CNN Headline News and CNN
International were initial customers for this new service. The agreement between
adam.com and CNN Newssource expires in January 2002.

                                       9
<PAGE>
ANATOMICAL REVIEW BOARD, EDITORIAL REVIEW BOARD, AND HEALTH ADVISORY BOARD

    We have an anatomical review board composed of individuals with expertise in
the fields of anatomy, biology and medicine to assist us in our endeavor to
ensure that the adam.com image database conforms to the highest standards of
anatomical accuracy and instructional utility. Members of the anatomical review
board make periodic recommendations to us with respect to content accuracy and
testing reliance of our products and product development candidates.

    With the release of AIA, we also established an editorial review board
composed of 125 educators and healthcare professionals to review the adam.com
image database and advise the product development teams on user interface
design, product features and functionality. The editorial review board provides
important feedback in helping us to create products and services that meet the
needs of the marketplace.

    We have established a health advisory board in conjunction with the launch
of the Web site. The board is expected to make periodic recommendations to us
with respect to content accuracy and reliability of information presented.
Members of the board are as follows:

    - Alan Greene, MD.

    Dr. Greene is currently in private practice at ABC Pediatrics in San Mateo,
California. He is the chairman of the Department of Pediatrics for
Mills/Peninsula Hospitals and on the clinical faculty at Stanford University
School of Medicine. He is the author of The Parent's Complete Guide to Ear
Infections, A Pound of Prevention: 16 Things You Can Do to Give Your Child a
Long and Healthy Life, the medical expert for additional publications. He became
one of the first online pediatricians when he appeared on the Web with Dr.
Greene's HouseCalls in 1996. His work has appeared in numerous publications,
including the Wall Street Journal, Consumer Reports, Parenting, Child, Baby
Talk, Woman's World, Better Homes & Gardens, and Reader's Digest. He has also
appeared frequently on television and radio shows as a medical expert.

    - William L. Holzemer, RN, PhD, FAAN.

    Dr. Holzemer is Professor and Chair of the Department of Community Health
Systems at the University of California, San Francisco School of Nursing. Prior
to this, he served as Associate Dean for Research in the school. Dr. Holzemer is
also the Director of the International Center for HIV/ AIDS Research and
Clinical Training in Nursing. Dr. Holzemer recently completed six years as a
chartered member and Chair of a National Institutes of Health study section. Dr.
Holzemer has published more than 80 refereed data-based research articles,
edited six books and authored thirteen book chapters. He recently completed a
collaborative research project funded by the NIH, National Institute of Nursing
Research, titled the Quality of Nursing Care for People with AIDS.

    - Suzanne Bakken Henry, RN, DNSc, FAAN.

    Dr. Henry is Associate Professor, Nursing and Medical Information Science,
University of California, San Francisco. Following her doctorate in nursing
science, Dr. Henry completed a National Library of Medicine--funded Postdoctoral
Fellowship in Medical Informatics at the Section on Medical Informatics,
Stanford University. She is an elected fellow of the American Academy of Nurses
and the American College of Medical Informatics. Dr. Henry currently serves as a
member of the Board of Directors of the American Medical Informatics Association
and is active in national healthcare standards efforts. Her program of research
in clinical informatics in the HIV population is supported through grants from
the National Institutes for Health.

    - Paul S. Auerbach, M.D., M.S., F.A.C.E.P.

    Dr. Auerbach is an emergency physician and a leading authority on wilderness
medicine. He is former Professor and Chief of the Divisions of Emergency
Medicine at Stanford and Vanderbilt Universities. Dr. Auerbach is currently
Clinical Professor of Surgery in the Division of Emergency

                                       10
<PAGE>
Medicine at Stanford, as well as COO for MedAmerica in Oakland, California. He
attained his medical degree at Duke University and is a graduate of the Sloan
Program at the Graduate School of Business at Stanford. Dr. Auerbach is a
co-founder and past President of the Wilderness Medical Society, and serves as
an advisor to numerous outdoor organizations. He is author of the textbook
Wilderness Medicine, as well as other publications. In addition, Dr. Auerbach is
Life Sciences Advisor to garage.com, and serves as an official Advisory Board
member to a number of health care information technology companies. Dr. Auerbach
is the recipient of the DAN America Award (1998) and Education Award (1999) from
the American College of Emergency Physicians.

    - Edmund Billings, MD.

    Dr. Billings, our Vice President and Chief Medical Officer, is the chair of
the Health Advisory Board. Dr. Billings was a co-founder of Oceania, Inc., a
health services company, and he acted as its Vice President of Product
Management and then General Manager of its Practice Products Group. He was
accountable for Oceania's product strategy, planning and design in delivering
Oceania Notes, a clinical documentation tool and knowledge base and the WAVE
Electronic Health Record. Before founding Oceania, Dr. Billings completed his
post-doctoral residency fellowships at Massachusetts General Hospital, Shriner's
Burn Institute in Boston, and at the University of California, San Diego.

MANUFACTURING

    The production of our software products includes CD-ROM pressing, assembly
of purchased product components, printing of product packaging and user manuals
and shipping of finished goods, which is performed by third-party vendors in
accordance with our specifications and forecasts. We believe that there are
alternate sources of these services that could be implemented without material
delay.

PROPRIETARY RIGHTS AND LICENSES

    We regard our software and the adam.com image database as proprietary. We
rely primarily on a combination of copyright, trademark, trade secret and
confidential information laws, employee and third-party nondisclosure agreements
and other methods to protect our proprietary rights. There can be no assurance
that these protections will be adequate to protect our intellectual property
rights or that our competitors will not independently develop technologies that
are substantially equivalent or superior to our technologies. We have obtained
federal registrations of the trademarks "A.D.A.M.," "SCHOLAR SERIES," "NINE
MONTH MIRACLE," and the "WALKING MAN" logo in the United States. We have applied
for registration of approximately ten additional trademarks in the United
States. We have also obtained registrations of the "A.D.A.M." trademark in 22
foreign countries. We have applications for registration of the mark pending in
an additional five countries. We do not currently hold any patents or have any
patent applications pending. We believe that, due to the rapid pace of
innovation within the multimedia and software industries, factors such as the
technological and creative skills of our personnel and the quality of the
content of our products are more important in establishing and maintaining a
leadership position within the industry than are the various legal protections
of its technology.

    We license certain software programs from third-party developers and
incorporate them into our products. Such software products are widely licensed
by the respective developers thereof for incorporation by other developers (like
adam.com) in their products and provide specific functionality required in order
to operate the product. For example, we license Macromind Director, a program
distributed by Macromedia, which permits a product to display animated
sequences. This product is incorporated in several adam.com products. Generally,
the licenses grant to us non-exclusive, worldwide rights with respect to the
subject program and terminate only upon a material breach by us. Certain of the
licenses require payment of annual license fees (not exceeding $25,000 per annum
in the aggregate). If a third-party agreement for licensed software expires or
terminates and we are unable to

                                       11
<PAGE>
renew or extend the agreement, we could be required to engage in independent
development of replacement software or to obtain a suitable replacement. We
generally believe that licenses for alternative software programs are available
on commercial terms from a number of licensors. We own and do not license the
anatomical illustrations included in the adam.com image database, but we license
certain additional multimedia content from various third parties that we
incorporate into our products, including video, photographs, music and text.
Such licenses generally provide us with fully-paid perpetual, worldwide licenses
to include the licensed content in a designated product.

    We believe that our products, trademarks and other proprietary rights do not
infringe upon the proprietary rights of third parties. However, as the number of
software products in the multimedia industry increases and the functionality of
these products further overlaps, software developers may become increasingly
subject to infringement claims. There can be no assurance that third parties
will not assert infringement claims against us in the future with respect to
current or future products, trademarks or other works of adam.com or that any
assertion will not require us to enter into royalty arrangements or result in
costly litigation.

COMPETITION

    There are many companies that provide Internet and non-Internet based
consumer health information and healthcare related product to the public. All of
these companies compete with us for sponsors, advertisers, and consumer spending
dollars and other Internet consumer health information providers also compete
with us for visitor traffic. We expect competition to continue escalating, as
there are no substantial barriers to entry in the online health information
market and consumer appetite for health related information continues to be
strong. Increased competition could result in reductions of the fees we will be
able to bill for sponsorship and advertising customers, or reduced visitor
traffic to our Web site. Any of these occurrences could materially and adversely
affect our new business model, financial condition and results of operation.
Competition is also likely to increase significantly, not only as new entities
enter the market, but also as current competitors expand their services.

    Our ability to compete in the Internet consumer health information
environment will depend on a number of factors including quality of content,
ease of use, timing and market acceptance of new and enhanced services, and
level of sales and marketing efforts. To be competitive, adam.com will need to
respond promptly and effectively to the challenges of technological change,
evolving standards and innovation by continuing to enhance the visitor's overall
interactive experience at the Web site, develop and maintain a loyal user base,
as well as establish an opportunity for commerce in proprietary and third party
products. Increased competition could result in a reduction of traffic to the
Web site, adversely affecting our ability to generate advertising and
sponsorship revenue.

    The educational multimedia software industry is intensely competitive and
demand for particular software products may be adversely affected by the
increasing number of available competitive products. We compete in the academic
marketplace primarily with other companies offering educational software
products on anatomy, health and medical topics and, to a lesser extent, with
larger publishers of traditional print textbooks on anatomy and medicine.
Existing competitors may continue to broaden their product lines and potential
competitors, including large hardware or software manufacturers and educational
publishers, may enter or increase their focus on the academic market, resulting
in greater competition for us.

EMPLOYEES

    As of March 31, 1998, adam.com had 62 employees. Of these, 27 were engaged
primarily in product development, 11 in sales, seven in marketing and 17 in
finance and administration. A total of 55 employees were based in our Atlanta
headquarters and seven were based in the San Francisco office. None of our
employees is covered by a collective bargaining agreement and we have
experienced no work stoppages. We consider our employee relations to be good. We
believe that our future growth

                                       12
<PAGE>
and success will depend upon our ability to retain and continue to attract
highly skilled and motivated personnel in all areas of our operations.

DISCLOSURE REGARDING FORWARD-LOOKING STATEMENTS

    Certain statements made in this report, and other written or oral statements
made by or on behalf of adam.com, may constitute "forward-looking statements"
within the meaning of the federal securities laws. When used in this report, the
words "believes," "expects," "estimates," "intends" and similar expressions are
intended to identify forward-looking statements. Statements regarding future
events and developments and our future performance, as well as our expectations,
beliefs, plans, intentions, estimates or projections relating to the future, are
forward-looking statements within the meaning of these laws. Examples of such
statements in this report include descriptions of our plans and strategies with
respect to developing the site, our plans to develop additional strategic
partnerships, our intention to add e-commerce to our business strategy, our
continuing growth and our ability to address Year 2000 issues. All
forward-looking statements are subject to certain risks and uncertainties that
could cause actual events to differ materially from those projected. We believe
that these forward-looking statements are reasonable; however, you should not
place undue reliance on such statements. These statements are based on current
expectations and speak only as of the date of such statements. We undertake no
obligation to publicly update or revise any forward-looking statement, whether
as a result of future events, new information or otherwise.

    The following are some of the factors that could cause our actual results to
differ materially from the expected results described in the our forward-looking
statements:

    - Our Internet operations have a limited operating history, and adam.com was
      commercially launched in May 1999. Therefore, our historical operating
      history provides little basis on which to evaluate our current business
      and prospects. Further, we may be unable to execute our revised strategy.

    - We have a history of losses and we expect to incur future losses. We
      expect to incur significant expenses in connection with the site.

    - We may be unable to continue to identify additional strategic partners,
      which would adversely affect our ability to achieve broad brand
      recognition and additional traffic to the site.

    - We may be unable to manage our growing Internet business, which would
      adversely affect our ability to obtain advertising dollars and our results
      of operations.

    - We may face shortages of personnel that have the technological training
      required in our business. We may be required to increase the wages that we
      pay and the benefits that we provide in order to attract and retain a
      sufficient number of qualified employees. Any such increase in wages could
      adversely affect our results of operations.

    - We rely heavily on third parties, including Internet service providers,
      for delivery of our health information through the Internet. The
      performance of these third parties is not within our control. If these
      Internet service providers experience difficulties, it could affect the
      traffic to our site and, ultimately, our revenue from advertisers and
      sponsors.

    - Competition for online health information is intense, and we will compete
      for advertising dollars with other companies that have more Internet
      experience than we do. Our business has low barriers to entry, and our
      competitors may be more successful than we are at obtaining revenue from
      advertisers and sponsors.

    - The Internet and related technologies could fail to develop in accordance
      with the demands of the market. Because we are focusing on our Internet
      strategy and discontinuing support of some of our CD-ROM products, any
      failure of Internet technologies would adversely affect our business.

                                       13
<PAGE>
    - Our intellectual property rights offer only limited protection against
      unauthorized use of our proprietary information. If a third party
      successfully pirated our information, our licensees could be unwilling to
      continue to pay for the use of our content.

    - Governmental regulation of the Internet is evolving, and we cannot predict
      whether new laws or regulations will be adopted that will adversely affect
      our business.

    - We may be unable to obtain additional funding to finance our growing
      business.

    - We may lose revenue or incur additional costs because of failure to
      adequately address the Year 2000 issue.

    - We will be affected by general economic conditions, which affect the
      overall level of economy.

ITEM 2. PROPERTIES

    Our headquarters are located in approximately 26,000 square feet of leased
office space in Atlanta, Georgia. The space is leased for a term ending in 2002.
In February 1999, we sub-leased approximately 3,400 square feet of our leased
space to another company through the remainder of our lease term.

    In January 1999, we leased approximately 2,700 square feet of office space
in San Francisco, California to accommodate the expansion of our Web site
management and production teams. In June 1999 another 1,468 square feet of space
was leased near the existing San Francisco location. We expect to consolidate
the two locations by leasing 12,259 square feet in September 1999 and, while
there can be no assurance that current negotiations will result in a finalized
lease for the targeted space, we believe that other suitable facilities are
available and can be procured quickly. We believe that these facilities, once
procured, will be adequate through at least 2000. If additional facilities are
required, we believe that suitable facilities will be available.

ITEM 3. LEGAL PROCEEDINGS

    On April 25, 1996, a shareholders' class action lawsuit in Fulton County
Superior Court in Atlanta, Georgia was filed against A.D.A.M. Software, Inc. and
certain of its then officers and directors. The complaint alleges violations of
sections 11, 12(2) and 15 of the Securities Act of 1933, violations of the
Georgia Securities Act and negligent misrepresentation arising out of alleged
disclosure deficiencies in connection with our initial public offering of common
stock which was completed on November 10, 1995. The complaint seeks compensatory
damages and reimbursements for plaintiff's fees and expenses. We and the other
named defendants have filed a motion to dismiss the claim, which is pending.

ITEM 4. SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

    No matters were submitted to a vote of security holders during the fourth
quarter of fiscal 1999.

                                       14
<PAGE>
PART II

ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY AND RELATED STOCKHOLDER MATTERS

    Our common stock is quoted on the Nasdaq National Market system under the
symbol "ADAM". The following table sets forth the high and low sales prices of
our common stock as reported by Nasdaq for the fiscal year ended March 31, 1998
("fiscal 1998") and 1999.

<TABLE>
<CAPTION>
                                                                                                         HIGH         LOW
                                                                                                         -----     ---------
<S>                                                                                                   <C>          <C>
FISCAL 1998
First Quarter.......................................................................................      2 5/16   1 3/4
Second Quarter......................................................................................       3 5/8   2
Third Quarter.......................................................................................       3 5/8   1 7/8
Fourth Quarter......................................................................................       3 1/4   2 1/8

FISCAL 1999
First Quarter.......................................................................................       6 5/8   2 7/8
Second Quarter......................................................................................       4 1/2   2 1/2
Third Quarter.......................................................................................       5 1/2   2 1/8
Fourth Quarter......................................................................................       7 5/8   2 15/16
</TABLE>

    At June 28, 1999 there were 164 record holders of our common stock.

    We have never paid or declared any cash dividends on our common stock and we
do not intend to pay dividends on our common stock in the near future. We
presently expect to retain its future anticipated earnings to finance
development of and expansion of our business. The payment by adam.com of
dividends, if any, on our common stock in the future is subject to the
discretion of our board of directors and will depend on our earnings, financial
condition, capital requirements and other relevant factors.

                                       15
<PAGE>
ITEM 6. SELECTED FINANCIAL DATA
<TABLE>
<CAPTION>
                                                                            FISCAL YEAR ENDED MARCH 31,
                                                               -----------------------------------------------------
<S>                                                            <C>        <C>        <C>        <C>        <C>
                                                                 1999       1998       1997       1996       1995
                                                               ---------  ---------  ---------  ---------  ---------

<CAPTION>
                                                                (IN THOUSANDS, EXCEPT PER SHARE AMOUNTS)
<S>                                                            <C>        <C>        <C>        <C>        <C>
STATEMENT OF OPERATIONS:
  Net revenues...............................................  $   5,242  $   6,888  $   4,591  $   6,447  $   5,742
  Cost and expenses:
    Cost of revenues.........................................      1,421      1,178      1,280      1,491        791
    Sales and marketing......................................      2,704      2,778      4,494      4,090      3,666
    Product development......................................      2,074      1,512      2,260      2,847      2,401
    General and administrative...............................      1,571      1,293      2,369      2,008      1,774
    Restructuring charge.....................................         47         --        490         --         --
                                                               ---------  ---------  ---------  ---------  ---------
      Total costs and expenses...............................      7,817      6,761     10,893     10,436      8,632
                                                               ---------  ---------  ---------  ---------  ---------
Income (loss) before income..................................     (2,575)       127     (6,302)    (3,989)    (2,890)
Interest income (expense), net...............................        395        526        861         98       (340)
                                                               ---------  ---------  ---------  ---------  ---------
    Income (loss) before income taxes and
    extraordinary item.......................................     (2,180)       653     (5,441)    (3,891)    (3,230)
Income taxes.................................................         --        (75)        --         --         --
                                                               ---------  ---------  ---------  ---------  ---------
    Net income (loss) before extraordinary item..............     (2,180)       578     (5,441)    (3,891)    (3,230)
Extraordinary loss from early extinguishment of debt, net of
  income tax benefit of $29..................................         --         --         --        (46)        --
                                                               ---------  ---------  ---------  ---------  ---------
    Net income (loss)........................................  $  (2,180) $     578  $  (5,441) $  (3,937) $  (3,230)
                                                               ---------  ---------  ---------  ---------  ---------
                                                               ---------  ---------  ---------  ---------  ---------
Net income (loss) per share..................................  $   (0.48) $     .12  $   (1.03) $   (1.14) $   (1.22)
                                                               ---------  ---------  ---------  ---------  ---------
                                                               ---------  ---------  ---------  ---------  ---------
Weighted average number of common shares and share
  equivalents outstanding, diluted...........................      4,528      4,959      5,258      3,673      2,694
                                                               ---------  ---------  ---------  ---------  ---------
                                                               ---------  ---------  ---------  ---------  ---------
</TABLE>
<TABLE>
<CAPTION>
                                                                                        AS OF MARCH 31,
                                                                     -----------------------------------------------------
<S>                                                                  <C>        <C>        <C>        <C>        <C>
                                                                       1999       1998       1997       1996       1995
                                                                     ---------  ---------  ---------  ---------  ---------

<CAPTION>
                                                                                        (IN THOUSANDS)
<S>                                                                  <C>        <C>        <C>        <C>        <C>
BALANCE SHEET DATA:
  Cash and cash equivalents........................................      2,369        704      2,422      5,352        940
  Working capital (deficiency).....................................      6,393      9,011      9,982     15,354     (1,736)
  Total assets.....................................................      8,970     11,900     13,662     18,871      4,247
  Short-term debt..................................................         --         --         --        250      2,530
  Long-term debt...................................................         --         --         --         --        298
  Convertible Preferred Stock......................................         --         --         --         --      2,022
  Total shareholders' equity (deficit).............................      7,796     10,713     11,555     16,896     (1,943)
</TABLE>

                                       16
<PAGE>
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS
        OF OPERATIONS

    THE FOLLOWING DISCUSSION SHOULD BE READ IN CONJUNCTION WITH THE FINANCIAL
STATEMENTS AND NOTES THERETO PRESENTED ELSEWHERE IN THIS ANNUAL REPORT ON FORM
10-K.

OVERVIEW

    We are a leading developer of health education content and software
technologies, and since January 1999, we have taken steps to become a leading
provider of health, medical and wellness information online. We have created,
published and marketed multimedia software products, content and Internet-ready
applications that provide anatomical, medical and health-related information for
the education, consumer and professional markets. We have historically sold our
products into the academic markets through alliances with distributors and by
direct sales and marketing activities, but since March 1999, we decided to
concentrate sales efforts exclusively by indirect distribution methods.

    During the final quarter of fiscal 1999, we began investment and focus on an
initiative to create the Web site for the purpose of providing the public with
health, medical and wellness information. We immediately began expansion of our
production, engineering, administrative, marketing and management teams in order
to launch our Web site, which debuted on May 10, 1999. During the final six
months of fiscal 1999, we formed strategic affiliate relationships with Internet
portals, other web sites, and traditional media outlets for the purpose of
achieving broader exposure of the adam.com brand. We believe these relationships
are a cost-effective method of acquiring and distributing healthcare content,
and ultimately as a means of driving high volumes of traffic to WWW.ADAM.COM. We
expect to earn advertising and licensing revenues from advertisers, merchants,
manufacturers and healthcare organizations who desire to reach a highly-targeted
community of healthcare consumers on the Internet.

    Revenue from product sales is generally recognized at the time of shipment
to customers, distributors and resellers or, in the case of consignment
arrangements, at the time of shipment from the consignee to their customers.
Revenues from royalty agreements are recognized as earned based upon performance
or product shipments. Licensing revenue is recognized when we have determined
that:

    (1) contracts are finalized in cases where no further performance by us is
       required or over the term of the contract in cases where further
       performance by us is required;

    (2) there are no significant return or acceptance provisions; and

    (3) fees from the arrangement are fixed and determinable.

    We record allowances for product returns based on historical experience and
anticipated returns. Payments received in advance of shipments are recorded as
deferred revenue in the balance sheet and are recognized as revenue when the
related software is shipped and all applicable obligations are fulfilled.

    Average net revenue for the 85,000 units of software sold in fiscal 1999
increased to approximately $49.00 per unit compared with approximately $36.00
per unit for 120,000 units sold in fiscal 1998 and $24.00 per unit for 189,000
units sold for the fiscal year ending March 31, 1997. This was a result, in
large part, of reduced unit sales of our lower priced consumer products in
fiscal 1999 and 1998. Unit shipments of lower priced, lower margin consumer
products were approximately 6,000, 48,000 and 137,000 for the fiscal years ended
March 31, 1999, 1998 and 1997, respectively. Approximately 79% of revenues in
fiscal 1999 were derived from actual product shipments, compared to 63% in
fiscal 1998 primarily due to revenue of $750,000 from a single, one-time
licensing agreement recorded as international market revenue during fiscal 1998.
During fiscal 1999, $601,000 was recognized from sales of education market
products to AWL and royalty revenue from sales by Benjamin Cummings (a

                                       17
<PAGE>
subsidiary of Addison Wesley) of co-developed education market products, and
$579,000 was recognized from sales of consumer and education market products to
Mindscape, Inc. We expect future sales of our CD-ROM products to decrease
significantly as we focus on our Internet strategies.

    We have experienced substantial losses since inception (except for a small
profit during fiscal 1998), resulting in an accumulated deficit of approximately
$24.1 million as of March 31, 1999. For the fiscal year ended March 31, 1999, we
incurred a net loss of $2.2 million as compared to net income of $578,000 for
the fiscal year ended March 31, 1998, and a net loss for the fiscal year ended
March 31, 1997 of approximately $5.4 million. We believe that revenue from sales
of software products will continue to decrease as less costly or free content
accessed through the Internet becomes more widely available. Accordingly, we
have and will continue to reduce efforts to sell software products through
traditional distribution models. However, we further believe that the Internet
represents a unique opportunity for us to leverage our content assets into an
"online" consumer health information strategy by both licensing content assets
to other Internet-based businesses and by driving consumers to its Web site.

    In January 1999, we leased approximately 2,700 square feet of office space
in San Francisco, California to accommodate the expansion of our Web site
management and production teams. In June 1999, we leased another 1,468 square
feet of space in San Francisco. We expect to consolidate both locations by
leasing 12,259 square feet in San Francisco location in September 1999. We
remain headquartered in Atlanta, Georgia and we do not expect the need for
additional capacity at that location as our major operations continue to expand
in San Francisco. In March 1999, we released substantially all of our Atlanta
based direct (software) sales team corresponding to the re-focus and commitment
to Internet strategies, and recorded a restructuring charge of $47,000 related
to severance costs.

    At March 31, 1999, we had net operating loss carryforwards available for tax
purposes of approximately $24 million, which will expire in years 2012 through
2019. Future sale of shares by certain significant shareholders could create a
substantial ownership change (as defined by the Internal Revenue Service) which
would limit the amount of future taxable income that may be offset by
pre-ownership net operating loss carryforwards.

RESULTS OF OPERATIONS

    The following table sets forth for the periods indicated selected financial
data and the percentages of our net revenues represented by each line item and
the percentage change in each line item.

<TABLE>
<CAPTION>
                                                                                              FISCAL YEAR ENDED MARCH 31,
                                                                                           ---------------------------------
<S>                                                                                        <C>        <C>          <C>
                                                                                             1999        1998        1997
                                                                                           ---------     -----     ---------
Net revenues.............................................................................        100%        100%        100%
Costs and expenses:
  Cost of revenues.......................................................................       27.1        17.1        27.9
  Sales and marketing....................................................................       51.6        40.3        97.9
  Product development....................................................................       39.5        22.0        49.2
  General and administration.............................................................       30.0        18.8        51.6
  Restructuring charge...................................................................        0.9          --        10.7
                                                                                           ---------         ---   ---------
    Total costs and expenses.............................................................      149.1        98.2       237.3
                                                                                           ---------         ---   ---------
Operating income (loss)..................................................................      (49.1)        1.8      (137.3)
</TABLE>

                                       18
<PAGE>
    The following table sets forth for the periods indicated the revenues
derived by us from product sales, license fees and royalty income in the
academic, consumer and professional markets and from other sources. Other
revenues include support services, such as training, and other non-market
specific sales. We expect future revenues from the sales of products to these
markets to decrease significantly as we focus on our Internet strategies.

<TABLE>
<CAPTION>
                                                                     FISCAL YEAR ENDED MARCH 31,
                                                                   -------------------------------
<S>                                                                <C>        <C>        <C>
                                                                     1999       1998       1997
                                                                   ---------  ---------  ---------
Education........................................................  $   4,068  $   5,357  $   2,523
Professional.....................................................        695        821         --
Consumer.........................................................        289        652      1,978
Other revenues...................................................        190         58         90
                                                                   ---------  ---------  ---------
    Net revenues.................................................  $   5,242  $   6,888  $   4,591
                                                                   ---------  ---------  ---------
                                                                   ---------  ---------  ---------
</TABLE>

FISCAL 1999 COMPARED TO FISCAL 1998

    Total net revenues decreased $1,646,000, or 23.9%, to $5,242,000 in fiscal
1999 compared to $6,888,000 in fiscal 1998. The decrease is primarily
attributable to (1) a $750,000 one time, 99-year international license agreement
executed in fiscal 1998, (2) decreased consumer product revenues and (3)
decreased product sales in international markets, reflective of the downturned
economic environments in overseas markets during fiscal 1999. In March 1997, we
ceased direct sales of product to the consumer market and outsourced
distribution to Mindscape. Total unit shipments of our CD-ROM products decreased
to approximately 85,000 units in fiscal 1999 from approximately 120,000 units in
fiscal 1998, but average revenue per unit increased 36% during this same period
resulting from higher priced, education market CD-ROM products and decreased
unit sales of lower priced consumer products.

    Net revenues from the education market decreased $1,289,000, or 24.0% to
$4,068,000 in fiscal 1999 from $5,357,000 in fiscal 1998 primarily due to the
one-time international license agreement in fiscal 1998 and decreased selling
prices for products not offset by increases in units sold. Additionally,
international unit product sales decreased $549,000, or 62.1% to $335,000 from
$884,000 in fiscal 1998 reflective of downturned economic markets abroad. As a
percent of total net revenues, net revenues from the education market remained
steady at 78% in fiscal 1999 compared to fiscal 1998.

    Net revenues from the professional market decreased $126,000, or 15.3%, to
$695,000 in fiscal 1999 from $821,000 in fiscal 1998. The decrease is primarily
attributable to a decrease in revenue related to MLI series products introduced
during fiscal 1997, which decreased 57% to $156,000 in fiscal 1999 compared to
$363,000 in fiscal 1998. The revenue was derived from sales of custom services,
license fees for software components developed by us, and product sales, each of
which accounted for 15%, 63% and 22% of total professional market net revenues,
respectively, in fiscal 1999, compared to 15%, 41% and 44% in fiscal 1998. As a
percent of total net revenues, net revenues from the professional market
increased to 13.3% in fiscal 1999 compared to 11.9% in fiscal 1998.

    Net revenues from the consumer market decreased $363,000, or 55.7% to
$289,000 in fiscal 1999 compared to $652,000 in fiscal 1998 due to reduced sales
activity, insignificant consumer product marketing expenditures, and
discontinued product upgrade for fiscal 1999. As a percent of total net
revenues, net revenues from the consumer market decreased to 5.5% in fiscal 1999
compared to 9.5% in fiscal 1998.

    Cost of revenues increased $243,000, or 20.6%, to $1,421,000 in fiscal 1999
compared to $1,178,000 in fiscal 1998. Cost of revenues, which includes the cost
of support, packaging, documentation, royalties and amortization of capitalized
software development costs, increased almost exclusively due to

                                       19
<PAGE>
amortization of capitalized software development costs which increased $220,000,
or 64.7%, to $560,000 in fiscal 1999 from $340,000 in fiscal 1998. The increase
in amortization is primarily the result of reductions in previously recorded
capitalized development costs in order to bring levels closer to expected future
revenues to be generated, or net realizable value (NRV). Reductions in net
realizable value are the result of our decision not to support certain products
moving forward and instead to focus on development and execution of our Internet
strategies. As a percent of total net revenues, cost of revenues increased to
27.1% in fiscal 1999 compared to 17.1% in fiscal 1998.

    Sales and marketing expenses decreased $74,000, or 2.7%, to $2,704,000 in
fiscal 1999 from $2,778,000 in fiscal 1998. The elimination of our direct sales
force as a result of a more indirect distribution model at the end of fiscal
1999 did not significantly reduce costs for that year, and other staffing levels
and costs remained consistent with fiscal 1998 levels. As a percent of total net
revenues, sales and marketing expenses increased to 51.6% in fiscal 1999 from
40.3% in fiscal 1998 resulting from the decrease in revenues described above.

    Product development costs increased $562,000, or 37.2%, to $2,074,000 in
fiscal 1999 compared to $1,512,000 in fiscal 1998. The increase in product
development costs is primarily attributable to (1) the shift in production
activity to research and development of the Web site, which is not subject to
capitalization of development costs and (2) our $1.2 million grant from the
National Institute of Science and Technology (NIST). As a percentage of total
net revenues, product development expenses increased to 39.6% in fiscal 1999
compared to 22.0% in fiscal 1998. Total expenditures for product development,
including capitalized expenses, increased 6.2% to $2,182,000 in fiscal 1999
compared to $2,054,000 in fiscal 1998. We capitalized product development
expenses of $108,000 and $542,000 in fiscal 1999 and fiscal 1998, which
represented 5.0% and 26.4% of total expenditure for product development in these
respective periods. Amortization of capitalized product development costs
totaled $560,000 and $340,000 in fiscal 1999 and fiscal 1998, and is included in
cost of revenues described above.

    General and administrative expenses increased $278,000, or 21.5%, to
$1,571,000 in fiscal 1999 from $1,293,000 in fiscal 1998. As a percentage of
total net revenues, general and administrative expenses increased to 30.0% in
fiscal 1999 compared to 18.8% in fiscal 1998. The increase was mainly due to
increased legal, bad debt, investor relations, and compensation expenses.

    Net interest income decreased $131,000, or 24.9%, to $395,000 in fiscal 1999
from $526,000 in fiscal 1998 due to reduced average cash and short-term
securities balances during fiscal 1999. The lower balances during fiscal 1999
are the result of our net loss during fiscal 1999 and the repurchase of our
common stock during both fiscal 1999 and fiscal 1998.

FISCAL 1998 COMPARED TO FISCAL 1997

    Total net revenues increased 50.0% to $6,888,000 in fiscal 1998 compared to
$4,591,000 in fiscal 1997 as a result of increased sales of our high-end,
flagship product in the education market, increased revenue from the
professional market and increased licensing revenue. Total unit shipments of our
products decreased to approximately 120,000 units in fiscal 1998 from
approximately 189,000 units in fiscal 1997. The increased net revenues and
decreased unit shipments reflect higher revenues per unit shipped, which are the
result of higher pricing for our flagship product, AIA, released in the first
quarter of fiscal 1998, distribution of lower priced consumer products such as
A.D.A.M. The Inside Story and Nine Month Miracle through a third party, and
greater focus on sale of higher margin education products during fiscal 1998.

                                       20
<PAGE>
    Net revenues from the education market increased 112.3% to 5,357,000 in
fiscal 1998 from $2,523,000 in fiscal 1997 due primarily to increased sales of
the flagship education product, AIA, as well as increased unit sales of other,
more mature products such as the Benjamin Cummings Interactive Physiology series
and APP. Our agreement with Kainos represented $750,000 of the education market
net revenues. In addition, in fiscal 1998 we recognized approximately $389,000
of revenue related to upgrade rights granted to purchasers of certain products
that was deferred during fiscal 1997. As a percent of total net revenues, net
revenues from the education market increased to 77.8% in fiscal 1998 compared to
54.9% in fiscal 1997.

    Net revenues from the consumer market decreased 67.0% to $652,000 in fiscal
1998 compared to $1,978,000 in fiscal 1997 due primarily to the March 1997
distribution agreement with Mindscape pursuant to which we receive royalties on
the sale of consumer products rather than recognizing gross sales price as it
had previously done. As a percent of total net revenues, net revenues from the
consumer market decreased to 9.5% in fiscal 1998 compared to 43.1% in fiscal
1997.

    Net revenues from the professional market were $821,000 in fiscal 1998.
These net revenues were derived from sales of custom services, license fees for
software components developed by us, and product sales each of which accounted
for 15%, 41%, and 44% of the total professional market net revenues,
respectively. Approximately 47% of product sales, or $170,000, into this market
resulted from sales of medical-legal series products introduced during fiscal
1997. As a percent of total net revenues, net revenues from the professional
market were 11.9% in fiscal 1998.

    Cost of revenues decreased 8.0% to $1,178,000 in fiscal 1998 compared to
$1,280,000 in fiscal 1997. Cost of revenues, which includes the cost of support,
packaging, documentation, royalties and amortization of capitalized software
development costs decreased primarily due to the significant reduction of
consumer product units shipped as a result of the Mindscape distribution
agreement reached in March 1997, partially offset by significant increases in
royalty expenses related to increased sales of IP series products, increased
capitalized software amortization and decreased software support costs. As a
percent of total net revenues, cost of revenues decreased to 17.1% in fiscal
1998 compared to 27.9% in fiscal 1997 due to changes in product mix,
specifically, the decreased unit sales of lower priced, lower margin consumer
products, increased sales of the higher margin, higher priced flagship education
product and the impact on net revenues from the recognition of income for
certain education product sales that was deferred in fiscal 1997.

    Sales and marketing expenses decreased 38.2% to $2,778,000 in fiscal 1998
from $4,494,000 in fiscal 1997, primarily as a result of decreased marketing
activities related to the sale and distribution of our consumer market products
as a result of the March 1997 Mindscape distribution agreement. Sales and
marketing costs attributable to sale and distribution of consumer products in
fiscal 1997 totaled $1,693,000 and was insignificant for fiscal 1998, accounting
for nearly the entire reduction in overall sales and marketing costs for fiscal
1998. As a percentage of total net revenues, sales and marketing expenses
decreased to 40.3% in fiscal 1998 from 97.9% in fiscal 1997.

    Product development costs decreased 33.1% to $1,512,000 in fiscal 1998 from
$2,260,000 in fiscal 1997 due primarily to decreases in salary and consulting
costs incurred in fiscal 1997 associated with the development of language
lexicons for our international products and maintenance of the consumer product
line in fiscal 1997. In addition, the amount of development costs capitalized
for fiscal 1998 increased by $41,000 compared to fiscal 1997, primarily
resulting from earlier achievement of "working models" in the development
process of products developed during fiscal 1998. As a percentage of total net
revenues, product development expenses decreased to 22.0% in fiscal 1998 from
49.2% in fiscal 1997. Total expenditures for product development, including
capitalized expenses, decreased to $2,054,000 in fiscal 1998 compared to
$2,761,000 in fiscal 1997. We capitalized product development expenses of
$542,000 and $501,000 in fiscal 1998 and fiscal 1997, respectively, which
represented 26.4% and 18.1% of total expenditure for product development in
these respective periods. Amortization of

                                       21
<PAGE>
capitalized product development cost totaled $340,000 and $119,000 in fiscal
1998 and 1997, respectively, and is included in cost of revenues described
above.

    General and administrative expenses decreased 45.4% to $1,293,000 in fiscal
1998 from $2,369,000 in fiscal 1997. As a percentage of total net revenues,
general and administrative expenses decreased to 18.8% in fiscal 1998 compared
to 51.6% in fiscal 1997. The decrease was mainly due to decreased legal, rent,
bad debt, investor relations, and salary expenses. Rent and salary decreases in
fiscal 1998 are the result of our restructuring in the second quarter of fiscal
1997.

    Interest income decreased 39.1% to $529,000 in fiscal 1998 from $869,000 in
fiscal 1997 due to reduced average cash and short-term securities balances
during fiscal 1998. The lower balances during fiscal 1998 are the result of our
net loss during fiscal 1997.

LIQUIDITY AND CAPITAL RESOURCES

    As of March 31, 1999, we had cash and cash equivalents of $2,369,000,
short-term investments of $3,792,000, and working capital of $6,393,000. Cash
used in operating activities was $861,000 in fiscal 1999, $344,000 in fiscal
1998 and $4,858,000 in fiscal 1997, principally as a result of net losses for
fiscal 1999 and fiscal 1997.

    We use our working capital to finance ongoing operations, fund the
development and introduction of new products and acquire capital equipment. As
of March 31, 1999, we had repurchased 847,240 shares of our common stock on the
open market at an average price of approximately $2.58 per common share for an
aggregate purchase price of approximately $2,186,000. Repurchased shares
represent approximately 16.0% of the shares of common stock issued and
outstanding as of March 31, 1999. Our board of directors has authorized us to
purchase up to 25% of the shares of common stock issued and outstanding.
However, additional repurchases are not anticipated at this time.

    We have experienced a substantial increase in our expenditures since the
launch of our San Francisco operation consistent with growth in operations and
staffing, and we anticipate that this will continue for the foreseeable future.
We anticipate incurring additional expenses to increase our marketing and sales
efforts, for content development and for technology and infrastructure
development. Additionally, we will continue to evaluate possible investments in
businesses, products and technologies, the expansion of our marketing and sales
programs and more aggressive brand promotions.

    We currently anticipate that our available cash resources will be sufficient
to meet our anticipated needs for working capital and capital expenditures at
least through the end of fiscal 2000. We may raise additional funds, however, in
order to fund more rapid expansion, to develop new and enhance existing services
and products, to respond to competitive pressures and to possibly acquire
complementary products, businesses or technologies. There can be no assurance
that any required additional financing will be available in terms favorable to
us, or at all. If additional funds are raised by the issuance of equity
securities, our shareholders may experience dilution of their ownership interest
and these securities may have rights senior to those of the holders of the
common stock. If additional funds are raised by the issuance of debt securities,
we may be subject to certain limitations on its operations, including
limitations on the payment of dividends. If adequate funds are not available or
not available on acceptable terms, we may be unable to fund our expansion,
successfully promote our brand name, take advantage of acquisition
opportunities, develop or enhance services or respond to competitive pressures,
any of which could have a material adverse effect on our business, financial
condition and results of operations.

                                       22
<PAGE>
YEAR 2000 COMPLIANCE

    The Year 2000 issue is the result of computer programs being written using
two digits rather than four to define the applicable year. Our computer
equipment and software and devices with imbedded technology that are
time-sensitive may recognize a date using "00" as the year 1900 rather than the
year 2000. This could result in a system failure or miscalculations causing
disruptions of operations including, among other things, a temporary inability
to process transactions, send invoices, or engage in similar normal business
activities

    We have an initiative to ensure that computer equipment and software will
function properly with respect to dates in the Year 2000 and thereafter. The
term "computer equipment and software" includes systems for product development,
production and testing, accounting, data processing, telephone/PBX, contact
management, and other miscellaneous systems as well as other systems not
traditionally thought of as "computer-related" technologies such as fax
machines, copiers, or other miscellaneous equipment and software. These systems
may contain imbedded technology, which complicate our Year 2000 identification,
assessment, remediation, and testing efforts. Based upon our identification and
assessment efforts to date, we believe that mission critical systems either are
currently, or are committed by our vendors to be Year 2000 compliant. We have
not directly surveyed our vendors as to Year 2000 compliance, but we plan to
avail ourselves of any remedies developed by systems vendors and/or publishers
that address current Year 2000 deficiencies, including currently known
deficiencies or those discovered prior to Year 2000. In addition, in the
ordinary course of replacing computer equipment and software, we will attempt to
obtain replacements that are Year 2000 compliant. By utilizing our internal
resources to ongoingly assess, test, and remediate potential and discovered Year
2000 issues, we believe that we are on schedule with the current initiative.

    Products we have developed have been internally tested for Year 2000
compliance by our quality assurance team. All internally developed products have
been confirmed as Year 2000 compliant; however, two products acquired by us from
Mosby, Inc. during fiscal 1998 are not Year 2000 compliant. We have decided not
to remedy the two products, and are not actively promoting the sale of those
products beyond fiscal 1999. Through March 31, 1999, we have sold approximately
$59,000, or 8,938 units of the non-compliant products. We estimate total
exposure to remedy, which is limited to refunding customers their original
purchase price, to be not greater than $25,000.

    We believe that the cost of our Year 2000 identification, assessment,
remediation and testing efforts will not exceed $50,000, which expenditures will
be funded from existing cash balances. Such amount represents less than 5% of
the actual and anticipated information system equipment, software technology,
and product production expenditures for fiscal 1999 and 2000. We estimate that
we have spent approximately $8,500 as of March 31, 1999 on quality assurance
testing of our products. Other non-Year 2000 product production and system
technology efforts have not been materially delayed or impacted by the Year 2000
initiative. We presently believe that the Year 2000 issue will not pose
significant operational problems for adam.com. However, if all Year 2000 issues
are not properly identified, there can be no assurance that the Year 2000 issue
will not materially adversely impact our results of operation or adversely
affect our relationships with customers, vendors or others. Additionally, there
can be no assurance that the Year 2000 issues of other entities will not have a
material adverse impact on our systems or results of operation.

    We have not yet begun a comprehensive analysis of the operational problems
and costs (including loss of revenues) that would be reasonably likely to result
from the failure by ourselves and certain third parties to complete efforts
necessary to achieve Year 2000 compliance on a timely basis. A contingency plan
has not been developed for dealing with the most reasonably likely worst case
scenario and such scenario has not yet been clearly identified. We currently
plan to complete such analysis and contingency planning by September 30, 1999.

                                       23
<PAGE>
    The costs of our Year 2000 identification, assessment, remediation and
testing efforts and the dates on which we believe we will complete such efforts
are based upon our best estimates, which were derived using numerous assumptions
regarding future events, including the availability of certain resources and
other factors. There can be no assurance that these estimates will prove to be
accurate and actual results could differ materially from those currently
anticipated. Specific factors that could cause such material differences
include, but are not limited to, the ability to identify, assess, and remediate
and test all relevant computer codes and embedded technology, and similar
uncertainties. In addition, variability of definitions of "compliance with Year
2000" and the myriad of different products and services, and combinations
thereof, sold by adam.com may lead to claims whose impact on adam.com is not
currently estimable. No assurance can be given that the aggregate cost of
defending and resolving such claims, if any, will not materially adversely
affect the our results of operation. Although some of the our agreements and
contracts with third parties contain provisions requiring such parties to
indemnify us under some circumstances, there can be no assurance that such
indemnification arrangements will cover all of our liabilities and costs related
to claims by third parties related to the Year 2000 issue.

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

    As of March 31, 1999, we had cash and cash equivalents of $2.4 million
invested in liquid money market funds or bank accounts with average maturities
of less than 90 days. The cash and cash equivalents are subject to interest rate
risk and we may receive higher or lower interest income if market interest rates
increase or decrease. A hypothetical increase or decrease in market interest
rates by 10 percent from levels at March 31, 1999 would not have a material
impact on our cash or cash equivalents.

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

    This information is set forth under Item 14(a)(1) and (2).

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND
        FINANCIAL DISCLOSURES.

    Not applicable.

                                       24
<PAGE>
PART III.

ITEM 10. DIRECTORS AND EXECUTIVE OFFICERS OF THE REGISTRANT

<TABLE>
<CAPTION>
NAME                                                       AGE                            POSITION
-----------------------------------------------------      ---      -----------------------------------------------------
<S>                                                    <C>          <C>
Robert S. Cramer, Jr.................................          39   Chairman of the Board, Chief Executive Officer and
                                                                    Director
Gregory M. Swayne....................................          41   Vice Chairman and Director
Michael S. Fisher....................................          36   Corporate Secretary and Director of Finance and
                                                                    Administration
Linda B. Davis.......................................          56   Director
Sally D. Elliot......................................          46   Director
Anthony J. Gatti.....................................          51   Director
Daniel S. Howe.......................................          38   Director
Hamilton M. Jordan...................................          54   Director
John W. McClaugherty.................................          39   Director
Francis J. Tedesco...................................          55   Director
</TABLE>

    ROBERT S. CRAMER, JR.  Mr. Cramer, a co-founder of adam.com, has served as
Chairman of the Board and a director since adam.com's inception in March 1990,
and Chief Executive Officer since September 1996. From 1987 to 1992, he served
as Chairman of the Board of Directors of MLI. In 1989, Mr. Cramer served as an
Executive Editor and Co-Publisher of Atlanta Computer Spectrum, a regional
technology publication he helped to create. Also, since 1994 Mr. Cramer has
served as Chairman of the Board of the Atlanta Task Force for the Homeless, a
community-wide non profit organization working with and on the behalf of
homeless people.

    GREGORY M. SWAYNE.  Mr. Swayne, a co-founder of adam.com, has served as Vice
Chairman of adam.com since March 1997 and as a director since March 1990.
Previously, he served as President of adam.com from March 1990 until March 1997
and Vice President of Production from March 1990 to March 1998. As the original
founder of Medical Legal Illustrations, Inc. ("MLI"), a predecessor to adam.com,
he served as President from 1985 until February 1992, and as a director of MLI
from 1985 until the merger of MLI and adam.com in May 1992. Mr. Swayne is a
master degreed medical illustrator who completed a three year graduate program
in medical illustration that required him to participate in all the first year
medical school courses (including gross anatomy, histology, embryology and
neuroanatomy) as well as a full year of direct surgical observation and
illustration.

    MICHAEL S. FISHER.  Mr. Fisher joined adam.com in September 1993 as
Controller, became Director of Finance and Administration in February 1997 and
was appointed Corporate Secretary in March 1997. From June 1990 through August
1993 he served as Controller for Morgan Medical Holdings, Inc., a publicly held
medical diagnostic services firm, and was responsible for all financial
functions. Previously thereto, he served two years as an accountant with
BDO/Seidman. Mr. Fisher is a CPA licensed in the state of New York.

    LINDA B. DAVIS  Ms. Davis has been a director of adam.com since September
1998. Ms. Davis is the General Manager of the Science and Nursing Division of
Addison Wesley, a position she has held since September 1997. She joined Addison
Wesley in 1990 as Vice President of Product Development and was subsequently
promoted to Vice President and Editorial Director of the Math, Physics and
Statistics Division. Previously, Ms. Davis was Vice President and Director of
Development at W.H. Freeman/Scientific American Books from 1986 to 1990.

    SALLY D. ELLIOTT.  Ms. Elliott, a director of adam.com since June 1993, has
been a consultant focusing on publishing, education and new media since January
1998. Ms. Elliott served as President of

                                       25
<PAGE>
the Consumer Publishing Group, Addison Wesley Longman ("Addison Wesley")
formerly known as Benjamin/Cummings Publishing Company ("Benjamin/Cummings"), a
publisher of college textbooks and a subsidiary of Addison Wesley, from July
1991 to December 1997. Prior thereto, Ms. Elliott served as General Manager of
Benjamin/Cummings from June 1989 to June 1991 and Editorial Director of
Benjamin/Cummings from June 1987 to June 1989.

    ANTHONY J. GATTI.  Dr. Gatti has been a director of adam.com since May 1993.
Dr. Gatti has been a doctor of podiatric medicine in private practice since
1974. He is Chief Executive Officer and a director of the Marietta Podiatry
Group, a preferred provider organization offering podiatry services to major
health providers, and a director of several other national and state podiatric
medicine groups. In addition, Dr. Gatti is Chief Executive Officer of Millennium
Design, a medical software company.

    DANIEL S. HOWE.  Mr. Howe has been a Director of adam.com since December
1996. Mr. Howe has been President of DSH Enterprises, Inc., a real estate
development and investment company, since January 1990.

    HAMILTON M. JORDAN.  Mr. Jordan, a Director of adam.com since October 1997,
has managed a strategic planning and consulting company focused primarily on
health, education and media since 1993. Previously, Mr. Jordan served as Vice
Chairman of Whittle Communications, a media and advertising technology company
from 1990 to 1993, and was the Chief Executive Officer and founder of the ATP
Tour, a men's professional tennis international governing body, from 1986 to
1990. Mr. Jordan served in The White House from 1977 until 1980 as Chief of
Staff to President Carter.

    JOHN W. MCCLAUGHERTY.  Mr. McClaugherty, a co-founder of adam.com, has
served as a director of adam.com since its inception in March 1990. Since 1994,
Mr. McClaugherty has served as President of J.S.K., Inc., a provider of medical
illustrations to the legal profession. Mr. McClaugherty served as Chief
Executive Officer of adam.com from its inception until March 1994. Prior
thereto, Mr. McClaugherty was the Vice President of Sales and Marketing and a
director of MLI from March 1985 until March 1990.

    FRANCIS J. TEDESCO.  Dr. Tedesco has been a director of adam.com since July
1996. He has served as Chief Executive Officer of Health Sciences University and
as President of the Medical College of Georgia ("MCG") since 1988, and has been
a Professor of Medicine at MCG since 1981. He also is a consultant to Dwight
David Eisenhower Medical Center--Fort Gordon, Georgia; Veterans Administration
Medical Center--Augusta, Georgia and Walter Reed Army Medical Center--
Washington, D.C. Prior to coming to MCG in 1978, Dr. Tedesco held academic
appointments beginning in 1971 at the Hospital of the University of
Pennsylvania; Washington University School of Medicine, St. Louis, Missouri; and
University of Miami School of Medicine. Dr. Tedesco currently serves on the
Board of Directors and is Vice President of the Georgia Division of the American
Cancer Society, and he is a director of URO Health, a medical products
manufacturer.

ELECTION TO THE BOARD

    Directors are elected to the Board for three-year terms, and one-third of
the Board members stand for election each year. The terms of Messrs. Cramer,
Gatti and McClaugherty are scheduled to expire at the annual meeting of
shareholders in 1999. The terms of Messrs. Howe, Tedesco and Ms. Davis are
scheduled to expire at the annual meeting of shareholders in 2000, and the terms
of Messrs. Jordan, Swayne and Ms. Elliot are scheduled to expire at the annual
meeting of shareholders in 2001.

                                       26
<PAGE>
MEETINGS OF THE BOARD OF DIRECTORS

    During the fiscal year ended March 31, 1999 ("fiscal 1999"), the Board held
6 meetings. Each director that served during fiscal 1999 attended at least 75%
of all Board meetings and the aggregate number of meetings held by all
committees on which the individual director served in fiscal 1999.

COMMITTEES OF THE BOARD OF DIRECTORS

    The Board has standing Audit, Stock Repurchase and Compensation/Stock Option
Committees that assist it in discharging its responsibilities. These committees,
their members and functions are discussed below.

    The Audit Committee, which held 1 meeting during fiscal 1999, is responsible
for recommending independent accountants, reviewing with the accountants the
scope and results of the audit engagement, and consulting with independent
accountants and management with regard to adam.com's accounting methods and
control procedures. The Audit Committee is composed of Ms. Elliott and Mr. Howe.

    The Stock Repurchase Committee, which held no meetings during fiscal 1999,
is responsible for adam.com's repurchase of its own shares pursuant to the Stock
Repurchase Program. The Stock Repurchase Committee is composed of Messrs. Cramer
(Chairman), Howe and Swayne.

    The Compensation/Stock Option Committee, which held 1 meeting during fiscal
1999, is responsible for reviewing recommendations from the Chairman of the
Board of Directors with regard to the compensation of officers of adam.com and
reporting to the Board of Directors its recommendations with regard to such
compensation and is responsible for operating and administering adam.com's 1991
Employee Stock Option Plan and its Amended and Restated 1992 Stock Option Plan.
The Compensation/Stock Option Committee is composed of Dr. Gatti and Mr. Howe.

SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE

    Section 16(a) of the Exchange Act requires our executive officers and
directors and persons who beneficially own more than ten percent of our common
stock to file with the Securities and Exchange Commission certain reports, and
to furnish copies thereof to us, with respect to each such person's beneficial
ownership of our equity securities. Based solely upon a review of the copies of
such reports furnished to us and certain representations of such persons, all
such persons have complied with the applicable reporting requirements.

                                       27
<PAGE>
ITEM 11. EXECUTIVE COMPENSATION

SUMMARY COMPENSATION TABLE

    The table below sets forth certain information relating to the compensation
earned during fiscal 1999, fiscal 1998 and the fiscal year ended March 31, 1997
("fiscal 1997") by our Chief Executive Officer and each of the other highest
paid executive officers whose total annual salary and bonus exceeded $100,000
during fiscal 1999 (collectively, the "Named Executive Officers").

<TABLE>
<CAPTION>
                                                                              LONG-TERM
                                                                         ANNUAL COMPENSATION               COMPENSATION
                                                                --------------------------------------  -------------------
                                                                                           SECURITIES           ALL
                                                     FISCAL                                UNDERLYING          OTHER
NAME AND PRINCIPAL POSITIONS                          YEAR      SALARY($)     BONUS($)     OPTIONS(#)   COMPENSATION($)(1)
-------------------------------------------------  -----------  ----------  -------------  -----------  -------------------
<S>                                                <C>          <C>         <C>            <C>          <C>
Robert S. Cramer, Jr.............................        1999   $  164,000           --       225,000(2)      $   1,906
Chief Executive Officer                                  1998      155,000           --       120,000(3)          2,111
                                                         1997      155,000           --            --            2,111

Gregory M. Swayne................................        1999   $  159,000           --       220,000(2)      $   2,039
Vice Chairman                                            1998      155,000           --       120,000(3)          2,257
                                                         1997      155,000           --            --            4,185
</TABLE>

------------------------

(1) Represents life insurance premiums paid on behalf of such executive
    officers.

(2) Includes 195,000 shares subject to previously-granted options repriced and
    reissued on January 14, 1999.

(3) Options to purchase these shares were repriced and reissued on January 14,
    1999.

OPTION GRANTS IN LAST FISCAL YEAR

    The following table provides information regarding stock options granted to
the Named Executive Officers during fiscal 1999.

<TABLE>
<CAPTION>
                                                    INDIVIDUAL GRANTS                           POTENTIAL REALIZABLE
                               ------------------------------------------------------------       VALUE AT ASSUMED
                                NUMBER OF                                                      ANNUAL RATES OF STOCK
                               SECURITIES       % OF TOTAL                                       PRICE APPRECIATION
                               UNDERLYING     OPTIONS GRANTED     EXERCISE OR                   FOR OPTION TERM (1)
                                 OPTIONS       TO EMPLOYEES       BASE PRICE    EXPIRATION   --------------------------
NAME                           GRANTED(#)     IN FISCAL YEAR     ($/SHARE)(1)      DATE         5%($)         10%($)
-----------------------------  -----------  -------------------  -------------  -----------  ------------  ------------
<S>                            <C>          <C>                  <C>            <C>          <C>           <C>
Robert S. Cramer, Jr.........      30,000              4.2%        $    3.69       4/20/08   $    180,319  $    287,127
                                  195,000(2)           27.6             5.25       1/14/09      1,667,581     2,655,344

Gregory M. Swayne............      25,000              3.5         $    3.69       4/20/08   $    150,266  $    186,425
                                  195,000(2)           27.6             5.25       1/14/09      1,667,581     2,655,344
</TABLE>

------------------------

(1) The potential realizable value portion of the foregoing table illustrates
    value that might be realized upon exercise of the options immediately prior
    to the expiration of their term, assuming the specified compounded rates of
    appreciation on the common stock over the term of the options. These numbers
    do not take into account plan provisions providing for termination of the
    option following termination of employment or nontransferability.

(2) Represents previously-granted options repriced and reissued on January 14,
    1999.

                                       28
<PAGE>
AGGREGATE OPTION EXERCISES IN LAST FISCAL YEAR AND FISCAL YEAR-END OPTION VALUE
  TABLE

    The following table shows the number and value of exercisable and
unexercisable options held by adam.com's Named Executive Officers as of the end
of fiscal 1999. No stock appreciation rights were outstanding in fiscal 1999. In
addition, no stock options were exercised during fiscal 1999.

<TABLE>
<CAPTION>
                                                                                           VALUE OF UNEXERCISED
                                                                                               IN-THE MONEY
                                                                  NUMBER OF UNEXERCISED        OPTIONS/SARS
                                                                    OPTIONS AT FISCAL     AT FISCAL YEAR-END ($)
                                                                      YEAR-END (#)             EXERCISABLE/
NAME                                                             EXERCISABLE/UNEXERCISABLE    UNEXERCISABLE(2)
---------------------------------------------------------------  -----------------------  -----------------------
<S>                                                              <C>                      <C>
Robert S. Cramer, Jr...........................................        42,167/238,333(1)    $    21,083/109,716
Gregory M. Swayne..............................................        42,167/233,333            21,083/100,667
</TABLE>

------------------------

(1) Does not include warrants to purchase 42,938 shares of common stock issued
    in connection with the Subordinated Bridge Notes.

(2) The closing price of our common stock on March 31, 1999 was $5.50.

    We have not awarded stock appreciation rights to any employee, we have no
long-term incentive plans, as that term is defined in SEC regulations, and we
have no defined benefit or actuarial plans covering any of our employees.

COMPENSATION OF DIRECTORS

    To date, directors have not received cash compensation for their services as
directors of adam.com. During fiscal 1999, no directors of adam.com were granted
options to purchase common stock.

EMPLOYMENT AGREEMENTS

    We have entered into employment agreements with Messrs. Cramer and Swayne.
Each agreement is currently scheduled to expire on December 31, 1999 (the
"Expiration Date") and is automatically renewable for successive one-year
periods unless written notice of non-renewal is given by either party. Each
agreement also may be terminated by us with or without cause or upon the
employee's death or inability to perform his duties on account of a disability
for a period of twelve consecutive months or by the employee. If any agreement
is terminated prior to the Expiration Date for any reason, except by the
employee, by us for cause or upon the employee's death or disability, we must
continue to pay the employee's base salary and bonus either (1) for the period
from the date of termination through the Expiration Date if the agreement is
terminated prior to the first anniversary thereof or (2) for the two year period
following the date of termination if the agreement is terminated after the first
anniversary thereof. If the agreement is terminated because of the death or
disability of the employee, we must pay the employee or his beneficiaries his
base salary and bonus for a period of one year following the date of
termination; provided, however, that, in the case of termination for disability,
we may elect, in lieu of making such payments, to provide the employee with
disability insurance coverage. The agreements provide for a minimum base salary
of $120,000 for each of Messrs. Cramer and Swayne, and for annual discretionary
bonuses. Each agreement also contains a two year noncompetition, customer and
employee nonsolicitation and confidentiality provision. In addition, we have
executed Employee Confidentiality, Nondisclosure and Noncompetition Agreements
with all of our employees.

REPORT ON REPRICING OF OPTIONS

    We granted certain options to our employees to purchase our common stock on
various dates since 1991. Some of these options were cancelled and new options
were granted on January 14, 1999. The repricing of options reflects the
consistent application of the policy of our Compensation Committee

                                       29
<PAGE>
regarding stock options. The Compensation Committee and Board of Directors
believe that to provide maximum incentive to employees, including senior
executives, incentive options should be granted at exercise prices equal to or
not materially in excess of the market price of our common stock. As a result of
this policy, options granted by the Board and approved by the Compensation
Committee at various dates since 1991 were cancelled and new options were
granted on January 14, 1999. The options were cancelled and new options were
granted in order to more accurately reflect the market value of our common
stock, determined by reference to the closing price of the stock as reported by
the Nasdaq Stock Market on that date.

    The following table sets forth information concerning all repricings of
options to purchase our common stock held by our executive officers during the
last ten completed fiscal years.

                           TEN-YEAR OPTION REPRICINGS

<TABLE>
<CAPTION>
                                                NUMBER OF                                                       LENGTH OF
                                               SECURITIES                                                    ORIGINAL OPTION
                                               UNDERLYING   MARKET PRICE OF  EXERCISE PRICE                  TERM REMAINING
                                                 OPTIONS     STOCK AT TIME       AT TIME      NEW EXERCISE     AT DATE OF
NAME                                  DATE     REPRICED(#)  OF REPRICING($)  OF REPRICING($)    PRICE($)        REPRICING
----------------------------------  ---------  -----------  ---------------  ---------------  -------------  ---------------
<S>                                 <C>        <C>          <C>              <C>              <C>            <C>
Robert S. Cramer..................    1/14/99      20,000      $    5.25        $    8.80       $    5.25          1 Year
Chief Executive Officer               1/14/99      75,000           5.25             8.50            5.25         7 Years
                                      1/14/99      20,000           5.25             6.00            5.25         8 Years
                                      1/14/99      20,000           5.25             7.00            5.25         8 Years
                                      1/14/99      20,000           5.25             8.00            5.25         8 Years
                                      1/14/99      20,000           5.25             9.00            5.25         8 Years
                                      1/14/99      20,000           5.25            10.00            5.25         8 Years

Gregory M. Swayne.................    1/14/99      20,000      $    5.25        $    8.80       $    5.25          1 Year
Vice Chairman                         1/14/99      75,000           5.25             8.50            5.25         7 Years
                                      1/14/99      20,000           5.25             6.00            5.25         8 Years
                                      1/14/99      20,000           5.25             7.00            5.25         8 Years
                                      1/14/99      20,000           5.25             8.00            5.25         8 Years
                                      1/14/99      20,000           5.25             9.00            5.25         8 Years
                                      1/14/99      20,000           5.25            10.00            5.25         8 Years
</TABLE>

COMPENSATION COMMITTEE INTERLOCKS AND INSIDER PARTICIPATION

    During fiscal 1999 our Compensation Committee consisted of Dr. Gatti and Mr.
Howe. During fiscal 1999, we did not engage in any transactions with the members
of the Compensation Committee. No member of the Compensation Committee was an
officer or employee of adam.com or any of our subsidiaries during fiscal 1999 or
any time prior thereto.

                                       30
<PAGE>
ITEM 12.   SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS OF MANAGEMENT

    The following table sets forth the beneficial ownership of shares of common
stock as of June 25, 1999 for (1) directors of adam.com, (2) the Named Executive
Officers, (3) the directors and executive officers of adam.com as a group and
(4) each shareholder of adam.com holding more than a 5% interest in adam.com.
Unless otherwise indicated in the footnotes, all of such interests are owned
directly, and the indicated person or entity has sole voting and disposition
power. The number of shares represents (a) the number of shares of common stock
the person beneficially owns plus (b) the number of shares issuable upon
exercise of currently exercisable options and warrants.

<TABLE>
<CAPTION>
                                                                                      NUMBER
                                                                                     OF SHARES
NAME AND ADDRESS OF                                                                 BENEFICIALLY
  BENEFICIAL OWNER(1)                                                                  OWNED      PERCENT OF CLASS(2)
----------------------------------------------------------------------------------  -----------  ---------------------
<S>                                                                                 <C>          <C>
Robert S. Cramer(3)...............................................................     642,590              13.8%
Gregory M. Swayne(4)..............................................................     256,187               5.5
Linda B. Davis....................................................................          --                --
Sally D. Elliott(5)...............................................................       3,333                 *
Dr. Anthony J. Gatti(6)...........................................................     200,000               4.3
Daniel S. Howe(7).................................................................      27,333                 *
Hamilton M. Jordan(5).............................................................       9,677                 *
John W. McLaugherty(8)............................................................      28,202                 *
Francis J. Tedesco, M.D...........................................................          --                --
Addison-Wesley Longman............................................................     700,000              15.2
James D. Oelschlager(9)...........................................................     418,750               9.1
Firestone Tire and Rubber Master Trust(10)........................................     356,250               7.7
Scott M. Smith(11)................................................................     272,500               5.9
All executive officers and directors as a group
  (9 persons)(12).................................................................   1,188,322              25.1%
</TABLE>

------------------------

*   Less than 1%.

(1) Unless otherwise indicated, the addresses of the persons listed is c/o
    adam.com, 1600 River Edge Parkway, Suite 800, Atlanta, Georgia 30328.

(2) Assumes 4,438,507 shares outstanding, excluding shares held in treasury by
    adam.com. Except as indicated in the footnotes set forth below, the persons
    named in the table, to adam.com's knowledge, have sole voting and investment
    power with respect to all shares of common stock shown as beneficially owned
    by them. The number of shares shown as owned by, and the voting power of,
    individual shareholders include shares which are not currently outstanding
    but which such shareholders are entitled to acquire or will be entitled to
    acquire within 60 days. Such shares are deemed to be outstanding for the
    purpose of computing the percentage of outstanding common stock owned by the
    particular shareholder, but are not deemed to be outstanding for the purpose
    of computing the percentage ownership of any other person.

(3) Includes 48,833 shares issuable upon exercise of outstanding options and
    42,938 shares issuable upon exercise of outstanding warrants.

(4) Includes 13,333 shares issuable upon exercise of outstanding options.

(5) Represents shares issuable upon exercise of outstanding options.

(6) Includes 108,500 shares jointly held by Dr. Gatti and his wife. Dr. Gatti
    shares voting and dispositive power with respect to the 108,500 shares and
    disclaims beneficial ownership of such shares. Includes 70,250 shares held
    by Anthony J. Gatti, D.P.M., P.C. Money Pension Plan of which

                                       31
<PAGE>
    Dr. Gatti is Trustee and over which Dr. Gatti holds sole voting and
    dispositive power. Dr. Gatti disclaims beneficial ownership of such shares.
    Includes 16,250 shares held by Anthony J. Gatti, D.P.M., P.C. Profit Sharing
    Plan, of which Dr. Gatti is Trustee and over which Dr. Gatti holds sole
    voting and dispositive power. Dr. Gatti disclaims beneficial ownership of
    such shares. Dr. Gatti's address is c/o A.D.A.M. Software, Inc., 1600
    RiverEdge Parkway, Suite 800, Atlanta, Georgia 30328.

(7) Represents 9,333 shares issuable upon exercise of outstanding options.

(8) Includes 2,000 shares issuable upon exercise of outstanding options.

(9) Includes 356,250 shares held by the Firestone Tire and Rubber Master Trust
    (the "Firestone Trust"), for which Oak Associates, of which Mr. Oelschlager
    is President, is the fund manager. Includes 12,500 shares held by the Oak
    Associates Profit Sharing Plan and Trust, of which Mr. Oelschlager is the
    trustee. Mr. Oelschlager's address is c/o Oak Associates, 3875 Embassy
    Parkway, Suite 250, Akron, Ohio 44333. The information included in the table
    is based upon a Schedule 13G filed with the Securities and Exchange
    Commission on February 11, 1997.

(10) The Firestone Trust's address is Chemical Bank, as trustee for Firestone
    Rubber and Tire Master Trust (R.D. 4615504) c/o Oak Associates, 3875 Embassy
    Parkway, Suite 250, Akron, Ohio 44333. The information included in the table
    is based upon a Schedule 13G filed with the Securities and Exchange
    Commission on February 11, 1997.

(11) Mr. Smith's address is c/o Camelot Management Corp., 10 Glenville Street,
    Greenwich, Connecticut 06831-3638. The information included in the table is
    based upon a Schedule 13G filed with the Securities and Exchange Commission
    on February 11, 1999.

(12) Includes 73,499 shares issuable upon exercise of outstanding options and
    42,938 shares issuable upon exercise of outstanding warrants.

                                       32
<PAGE>
ITEM 13.   CERTAIN TRANSACTIONS

    During fiscal 1999, we sold approximately $353,000 of product to AWL, a
shareholder of adam.com. Linda B. Davis, one of our directors, is an affiliate
of Addison Wesley. In addition, we earned royalty revenues of approximately
$248,000 during fiscal 1999 related to Benjamin/Cummings, a subsidiary of
Addison Wesley.

    It is our policy that all future transactions, if any, with affiliated
parties will be approved by the disinterested members of our Board of Directors
(or a committee thereof) or by the shareholders of adam.com.

                                       33
<PAGE>
PART IV

ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES, AND REPORTS ON FORM 8-K

    (a) The following documents are included as part of this report:

<TABLE>
<CAPTION>
                                                                                           PAGE
                                                                                         ---------
<S>                                                                                      <C>
(1) FINANCIAL STATEMENTS:
Report of Independent Accountants......................................................        F-1
Balance Sheet at March 31, 1999 and 1998...............................................        F-2
Statement of Operations for the three years ended March 31, 1999.......................        F-3
Statement of Changes in Shareholders' Equity for the three years ended March 31,               F-4
  1999.................................................................................
Statement of Cash Flows for the three years ended March 31, 1999.......................        F-5
Notes to Financial Statements..........................................................        F-6

(2) FINANCIAL STATEMENT SCHEDULE:
For the three years ended March 31, 1999...............................................         F-
  II--Valuation and Qualifying Accounts
</TABLE>

                                       34
<PAGE>
    All other schedules have been omitted because they are not applicable or are
not required or the information required to be set forth therein is included in
the Financial Statements or Notes thereto.

<TABLE>
<CAPTION>
  EXHIBIT
    NO.                                                   DESCRIPTION
------------  ----------------------------------------------------------------------------------------------------
<C>           <S>

      3.1(a)  Amended and Restated Articles of Incorporation of the Company.
      3.2(a)  Amended and Restated By-Laws of the Company.
         4.1  Amended and Restated Articles of Incorporation of the Company (incorporated by reference to Exhibit
              3.1).
         4.2  Amended and Restated By-Laws of the Company (incorporated by reference to Exhibit 3.2).
      4.3(a)  Specimen Common Stock Certificate
      4.4(a)  Form of Option Certificate relating to the Company's 1992 Stock Option Plan
      4.5(a)  Form of Warrants to Purchase shares of Common Stock, dated April through November 1994
     10.1(a)  Amended and Restated 1992 Stock Option Plan
     10.2(a)  401(k) Adoption Agreement and Trust.
     10.3(a)  Employment Agreement between the Company and Robert S. Cramer, Jr., dated December 21, 1994.
     10.4(a)  Employment Agreement between the Company and Gregory M. Swayne, dated December 19, 1994.
     10.5(a)  Publishing Agreement by and between Williams & Wilkins and the Company, dated February 22, 1994
  10.7(a)(b)  Software Reseller Agreement among the Company, Addison Wesley Longman, through its Addison
              Wesley/Benjamin Cummings Group Sales Force Division, Benjamin/Cummings, and Addison Wesley
              Publishers Ltd., dated as of August 4, 1994.
  10.8(a)(b)  Software Reseller Agreement among the Company and Addison Wesley Longman, through its Addison Wesley
              School Division, dated as of February 9, 1995.
    10.17(c)  Localization Agreement between ZEMI Corp. and the Company dated June 7, 1996.
    10.20(d)  Asset Purchase and Sale agreement between Mosby, Inc. and the Company dated October 16, 1998.
    10.21(d)  Copyright License Agreement between Kainos Laboratories, Inc. and the Company, dated December 29,
              1997
    10.22(d)  License Agreement between CNN Newssource, Inc. and the Company dated January 15, 1998.
        23.1  Consent of PricewaterhouseCoopers LLP
        27.1  Financial Data Schedule--March 31, 1999 (for SEC use only)
</TABLE>

------------------------

(a) Incorporated by reference to the Company's Registration Statement on Form
    S-1, File No. 33-96864, dated September 12, 1995, as amended).

(b) The Company has been granted confidential treatment of portions of this
    Exhibit. Accordingly, portions thereof have been omitted and filed
    separately.

(c) Incorporated by reference to the Company's Annual Report on Form 10-K for
    the fiscal year ended March 31, 1996.

(d) Incorporated by reference to the Company's Annual Report on Form 10-K for
    the fiscal year ended March 31, 1998.

(B) REPORTS ON FORM 8-K

    No reports on Form 8-K have been filed with the Securities and Exchange
Commission during the fourth quarter of fiscal 1997.

                                       35
<PAGE>
    Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned, thereunto duly authorized.

<TABLE>
<S>                                           <C>        <C>
                                              A.D.A.M. SOFTWARE, INC.
                                              (Registrant)

                                              By:        /s/ ROBERT S. CRAMER, JR.
                                                         ----------------------------------------
                                                         Robert S. Cramer, Jr.
                                                         Chairman of the Board, Co-Founder, Chief
                                                         Executive Officer, and Director
                                                         Date: June 29, 1999
</TABLE>

    KNOW ALL MEN BY THESE PRESENT, that each person whose signature appears
below constitutes and appoints Robert S. Cramer, Jr. and Gregory M. Swayne, and
each of them, his or her true and lawful attorney-in-fact and agents, with full
power of substitution and resubstitution, from such person and in each person's
name, place and stead, in any and all capacities, to sign any and all amendments
to this Form 10-K, and to file the same, with all exhibits thereto and other
documents in connection therewith, with the Securities and Exchange Commission,
granting unto said attorneys-in-fact and agents, full power and authority to do
and perform each and every act and thing requisite and necessary to be done as
fully to all intents and purposes as he or she might or could do in person,
hereby ratifying and confirming all that said attorneys-in-fact and agents, or
any of them, may lawfully do or cause to be done by virtue thereof.

                                       36
<PAGE>
    Pursuant to the requirements of the Securities Exchange Act of 1934, this
report has been signed below by the following persons on behalf of the
Registrant and in the capacities indicated, on June 29, 1999.

<TABLE>
<CAPTION>
                       SIGNATURE                                                   TITLE
--------------------------------------------------------  --------------------------------------------------------
<C>                                                       <S>
               /s/ ROBERT S. CRAMER, JR.                  Chairman of the Board, Co-Founder, Chief Executive
      --------------------------------------------        Officer, and Director (Principal Executive Officer)
                 Robert S. Cramer, Jr.

                 /s/ GREGORY M. SWAYNE                    Vice Chairman, Co-Founder, Vice-President of Production
      --------------------------------------------        and Director
                   Gregory M. Swayne

                 /s/ MICHAEL S. FISHER                    Director of Finance/Administration
      --------------------------------------------        (Principal Financial Officer)
                   Michael S. Fisher

                                                          Director
      --------------------------------------------
                  John W. McClaugherty

                                                          Director
      --------------------------------------------
                    Sally D. Elliott

                                                          Director
      --------------------------------------------
                  Dr. Anthony J. Gatti

                    /s/ LINDA DAVIS                       Director
      --------------------------------------------
                      Linda Davis

                   /s/ DANIEL S. HOWE                     Director
      --------------------------------------------
                     Daniel S. Howe

              /s/ FRANCIS J. TEDESCO, M.D.                Director
      --------------------------------------------
                Francis J. Tedesco, M.D.

                  /s/ HAMILTON JORDAN                     Director
      --------------------------------------------
                    Hamilton Jordan
</TABLE>

                                       37
<PAGE>
                            A.D.A.M. SOFTWARE, INC.
                              FINANCIAL STATEMENTS
                            MARCH 31, 1999 AND 1998
<PAGE>
                       REPORT OF INDEPENDENT ACCOUNTANTS

To the Board of Directors and Shareholders of
A.D.A.M. Software, Inc.

    In our opinion, the financial statements listed in the index appearing under
Item 14(a)(1) and (2) on page 34 present fairly, in all material respects, the
financial position of A.D.A.M. Software, Inc., at March 31, 1999 and 1998, and
the results of its operations and its cash flows for each of the three years in
the period ended March 31, 1999, in conformity with generally accepted
accounting principles. These financial statements are the responsibility of the
Company's management; our responsibility is to express an opinion on these
financial statements based on our audits. We conducted our audits of these
statements in accordance with generally accepted auditing standards which
require that we plan and perform the audit to obtain reasonable assurance about
whether the financial statements are free of material misstatement. An audit
includes examining, on a test basis, evidence supporting the amounts and
disclosures in the financial statements, assessing the accounting principles
used and significant estimates made by management, and evaluating the overall
financial statement presentation. We believe that our audits provide a
reasonable basis for the opinion expressed above.

/s/ PRICEWATERHOUSECOOPERS LLP
Atlanta, GA
May 14, 1999

                                      F-1
<PAGE>
                            A.D.A.M. SOFTWARE, INC.

                                 BALANCE SHEET

                       (IN THOUSANDS, EXCEPT SHARE DATA)

<TABLE>
<CAPTION>
                                                                                                    MARCH 31,
                                                                                               --------------------
<S>                                                                                            <C>        <C>
                                                                                                 1999       1998
                                                                                               ---------  ---------
                                                      ASSETS
Current assets
  Cash and cash equivalents..................................................................  $   2,369  $     704
  Investment securities......................................................................      3,792      7,664
  Accounts receivable, net of allowances of $373 and $162....................................        950      1,239
  Inventories................................................................................        292        467
  Prepaids and other.........................................................................        164        124
                                                                                               ---------  ---------
      Total current assets...................................................................      7,567     10,198
Property and equipment, net..................................................................        644        496
Software development costs, net..............................................................        237        689
Restricted time deposits.....................................................................        522        517
                                                                                               ---------  ---------
      Total assets...........................................................................  $   8,970  $  11,900
                                                                                               ---------  ---------
                                                                                               ---------  ---------
                                       LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities
  Accounts payable...........................................................................  $     332  $     318
  Accrued liabilities........................................................................        352        375
  Accrued compensation and employee benefits.................................................        208        247
  Deferred rent..............................................................................        160        209
  Deferred revenue...........................................................................        122         38
                                                                                               ---------  ---------
      Total current liabilities..............................................................      1,174      1,187
                                                                                               ---------  ---------
Commitments and contingencies

Shareholders' equity
  Preferred stock, no par value; 9,062,500 shares authorized; no shares issued and
    outstanding..............................................................................         --         --
  Common stock, $0.01 par value; 20,000,000 shares authorized; 5,285,747 and 5,274,647 shares
    issued and outstanding, respectively.....................................................         53         52
  Common stock warrants......................................................................        135        135
  Additional paid-in capital.................................................................     33,911     33,883
  Treasury stock at cost, 847,240 and 602,550 shares, respectively...........................     (2,186)    (1,420)
  Accumulated deficit........................................................................    (24,117)   (21,937)
                                                                                               ---------  ---------
      Total shareholders' equity.............................................................      7,796     10,713
                                                                                               ---------  ---------
      Total liabilities and shareholders' equity.............................................  $   8,970  $  11,900
                                                                                               ---------  ---------
                                                                                               ---------  ---------
</TABLE>

   The accompanying notes are an integral part of these financial statements.

                                      F-2
<PAGE>
                            A.D.A.M. SOFTWARE, INC.

                            STATEMENT OF OPERATIONS

                     (IN THOUSANDS, EXCEPT PER SHARE DATA)

<TABLE>
<CAPTION>
                                                                                          YEAR ENDED MARCH 31,
                                                                                     -------------------------------
<S>                                                                                  <C>        <C>        <C>
                                                                                       1999       1998       1997
                                                                                     ---------  ---------  ---------
Net revenues.......................................................................  $   5,242  $   6,888  $   4,591
                                                                                     ---------  ---------  ---------
Cost and expenses
  Cost of revenues.................................................................      1,421      1,178      1,280
  Sales and marketing..............................................................      2,704      2,778      4,494
  Product development..............................................................      2,074      1,512      2,260
  General and administrative.......................................................      1,571      1,293      2,369
  Restructuring charge.............................................................         47         --        490
                                                                                     ---------  ---------  ---------
                                                                                         7,817      6,761     10,893
                                                                                     ---------  ---------  ---------
      Operating income (loss)......................................................     (2,575)       127     (6,302)
Interest income, net...............................................................        395        526        861
                                                                                     ---------  ---------  ---------
      Income (loss) before income taxes............................................     (2,180)       653     (5,441)
Income taxes.......................................................................         --        (75)        --
                                                                                     ---------  ---------  ---------
      Net income (loss)............................................................  $  (2,180) $     578  $  (5,441)
                                                                                     ---------  ---------  ---------
                                                                                     ---------  ---------  ---------
Net income (loss) per share
  Basic and diluted................................................................  $   (0.48) $    0.12  $   (1.03)
                                                                                     ---------  ---------  ---------
                                                                                     ---------  ---------  ---------
Weighted average common shares outstanding
  Basic............................................................................      4,528      4,916      5,258
                                                                                     ---------  ---------  ---------
                                                                                     ---------  ---------  ---------
  Diluted..........................................................................      4,528      4,959      5,258
                                                                                     ---------  ---------  ---------
                                                                                     ---------  ---------  ---------
</TABLE>

   The accompanying notes are an integral part of these financial statements.

                                      F-3
<PAGE>
                            A.D.A.M. SOFTWARE, INC.

                  STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY

                       (IN THOUSANDS, EXCEPT SHARE DATA)

<TABLE>
<CAPTION>
                                                  COMMON STOCK        ADDITIONAL     COMMON
                                             -----------------------    PAID-IN       STOCK     ACCUMULATED   TREASURY
                                               SHARES      AMOUNT       CAPITAL     WARRANTS      DEFICIT       STOCK      TOTAL
                                             ----------  -----------  -----------  -----------  ------------  ---------  ---------
<S>                                          <C>         <C>          <C>          <C>          <C>           <C>        <C>
BALANCE AT MARCH 31, 1996..................   5,234,647   $      52    $  33,783    $     135    $  (17,074)  $      --  $  16,896

Exercise of common stock options...........      40,000          --          100           --            --          --        100
Net loss...................................          --          --           --           --        (5,441)         --     (5,441)
                                             ----------         ---   -----------       -----   ------------  ---------  ---------

BALANCE AT MARCH 31, 1997..................   5,274,647          52       33,883          135       (22,515)         --     11,555

Repurchase of stock........................          --          --           --           --            --      (1,420)    (1,420)
Net income.................................          --          --           --           --           578          --        578
                                             ----------         ---   -----------       -----   ------------  ---------  ---------

BALANCE AT MARCH 31, 1998..................   5,274,647          52       33,883          135       (21,937)     (1,420)    10,713

Exercise of common stock options...........      11,100           1           28           --            --          --         29
Repurchase of stock........................          --          --           --           --            --        (766)      (766)
Net loss...................................          --          --           --           --        (2,180)         --     (2,180)
                                             ----------         ---   -----------       -----   ------------  ---------  ---------

BALANCE AT MARCH 31, 1999..................   5,285,747   $      53    $  33,911    $     135    $  (24,117)  $  (2,186) $   7,796
                                             ----------         ---   -----------       -----   ------------  ---------  ---------
                                             ----------         ---   -----------       -----   ------------  ---------  ---------
</TABLE>

   The accompanying notes are an integral part of these financial statements.

                                      F-4
<PAGE>
                            A.D.A.M. SOFTWARE, INC.

                            STATEMENT OF CASH FLOWS

                                 (IN THOUSANDS)

<TABLE>
<CAPTION>
                                                                                         YEAR ENDED MARCH 31,
                                                                                    -------------------------------
<S>                                                                                 <C>        <C>        <C>
                                                                                      1999       1998       1997
                                                                                    ---------  ---------  ---------
Cash flows from operating activities
  Net income (loss)...............................................................  $  (2,180) $     578  $  (5,441)
  Adjustments to reconcile net income (loss) to net cash used in operating
    activities
    Depreciation and amortization.................................................        906        707        576
    Changes in assets and liabilities
      Accounts receivable.........................................................        288       (601)      (190)
      Inventories.................................................................        175        (92)        58
      Prepaids and other assets...................................................        (39)       (16)         7
      Accounts payable and accrued liabilities....................................        (46)      (504)       (36)
      Deferred rent...............................................................        (49)        36        (72)
      Deferred revenue............................................................         84       (452)       490
      Third party advances........................................................         --         --       (250)
                                                                                    ---------  ---------  ---------
        Net cash used in operating activities.....................................       (861)      (344)    (4,858)
                                                                                    ---------  ---------  ---------
Cash flows from investing activities
  Purchases of short-term investments.............................................    (22,475)   (32,116)   (29,363)
  Proceeds from maturities of short-term investments..............................     26,343     32,998     31,798
  Purchases of property and equipment.............................................       (494)      (134)      (297)
  Redemption of restricted time deposit...........................................        160         --        191
  Purchase of restricted time deposit.............................................       (162)      (160)        --
  Software development costs......................................................       (108)      (542)      (501)
                                                                                    ---------  ---------  ---------
        Net cash provided by investing activities.................................      3,264         46      1,828
                                                                                    ---------  ---------  ---------
Cash flows from financing activities
  Proceeds from issuance of common stock upon exercise of stock options...........         28         --        100
  Repurchase of common stock......................................................       (766)    (1,420)        --
                                                                                    ---------  ---------  ---------
        Net cash provided by (used) in financing activities.......................       (738)    (1,420)       100
                                                                                    ---------  ---------  ---------
Increase (decrease) in cash and cash equivalents..................................      1,665     (1,718)    (2,930)
Cash and cash equivalents, beginning of period....................................        704      2,422      5,352
                                                                                    ---------  ---------  ---------
Cash and cash equivalents, end of period..........................................  $   2,369  $     704  $   2,422
                                                                                    ---------  ---------  ---------
                                                                                    ---------  ---------  ---------
</TABLE>

   The accompanying notes are an integral part of these financial statements.

                                      F-5
<PAGE>
                            A.D.A.M. SOFTWARE, INC.

                         NOTES TO FINANCIAL STATEMENTS

1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

    A.D.A.M. Software, Inc. (A.D.A.M. or the Company) creates, publishes and
markets educational multimedia software products that provide anatomical,
medical, scientific and health-related information for the academic,
professional, and consumer markets. The Company sells its products into the
academic and consumer markets through alliances with distributors and original
equipment manufacturers (OEMs) and by direct sales and marketing activities.
A.D.A.M.-Registered Trademark- products incorporate internally developed,
original medical illustrations with text, audio, photography, animation and
video in easy-to-use, interactive software applications. During the fourth
quarter of fiscal 1999, the Company began to focus primarily on Internet-based
opportunities. The Company created a website, "adam.com", for the purpose of
becoming a leading provider of consumer health information and a leading
developer of health education content and software technologies.

USE OF ESTIMATES

    The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amounts of net revenues and expenses during the
reporting period. Actual results could differ from those estimates.

REVENUE RECOGNITION

    Revenues are primarily derived from the sale of software products, license
agreements and from royalty agreements. Revenue from product sales is generally
recognized at the time of shipment to customers, distributors or resellers or,
in the case of consignment arrangements, at the time of shipment from the
consignee to its customers. Revenues from royalty agreements are recognized as
earned based upon performance or product shipment. Revenue from license sales
are recognized after delivery when the Company has determined that the fees from
the agreement are fixed and determinable and there are no significant return or
acceptance provisions. Payments, or instalment invoices for license agreements,
received in advance of shipments are recorded as deferred revenue in the
accompanying balance sheet and are recognized as revenue when the related
software is shipped. The Company did not have any advertising or e-commerce
related revenue from its internet site.

    Allowances for estimated product returns are provided at the time of sale.
The Company evaluates the adequacy of allowances for returns and doubtful
accounts primarily based upon its evaluation of historical and expected sales
experience and by channel of distribution. The estimates determined for reserves
for returns and allowances are based upon information available at the reporting
date. To the extent the future market, sell through experience, channels of
distribution and general economic conditions change, the estimated reserves
required for returns and allowances may also change.

CONCENTRATION OF CREDIT RISK

    Financial instruments that potentially subject the Company to concentration
of credit risk consist primarily of marketable securities and trade receivables.
The Company restricts investment of marketable securities to short-term
investment grade securities and direct or guaranteed obligations of the United
States government.

                                      F-6
<PAGE>
                            A.D.A.M. SOFTWARE, INC.

                   NOTES TO FINANCIAL STATEMENTS (CONTINUED)

1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)
FAIR VALUE OF FINANCIAL INSTRUMENTS

    The carrying amounts of the Company's financial instruments, including cash
and cash equivalents, accounts receivable, accounts payable, accrued expenses
and other liabilities, approximate fair value due to their short maturities.

CASH AND CASH EQUIVALENTS

    Cash and cash equivalents include cash on hand and or deposit and highly
liquid investments with an original maturity of three months or less.

INVENTORIES

    Inventories consist principally of computer software media and related
shipping materials and are stated at the lower of cost or market. Cost is
determined using the first-in, first-out method.

PROPERTY AND EQUIPMENT

    Property and equipment are recorded at cost, less accumulated depreciation
and amortization. Depreciation and amortization are provided using the
straight-line method for financial reporting purposes and accelerated methods
for income tax purposes over the estimated useful lives of three to five years.

SOFTWARE DEVELOPMENT COSTS

    Capitalized software development costs consist principally of salaries and
certain other expenses directly related to development and modifications of
software products capitalized in accordance with the provisions of Statement of
Financial Accounting Standards (SFAS) No. 86, "Accounting for the Costs of
Computer Software to be Sold, Leased, or Otherwise Marketed". Capitalization of
such costs begins when a working model has been produced as evidenced by
completion of design, planning, coding and testing such that the product meets
its design specifications and has thereby established technological feasibility
as defined in SFAS No. 86. Capitalization of such costs ends when the resulting
product is available for general release to the public. Amortization of
capitalized software development costs is provided at the greater of the ratio
of current product revenue to the total of current and anticipated product
revenue or on a straight-line basis over the estimated economic life of the
software, which the Company has determined to be in the range of eighteen to
twenty-four months. It is reasonably possible that those estimates of
anticipated product revenues, the remaining estimated economic life of the
product, or both will be reduced significantly in the near term due to changing
technologies. As a result, the carrying amount of capitalized software costs may
be reduced materially in the near term.

PRODUCT DEVELOPMENT

    Product development includes costs incurred in the development of internal
software for deployment of content to the Company's web sites and the actual
development and maintenance of the web page content. Development costs of
internal software used for deployment of content to the Company's web sites has
been charged to expense as incurred.

                                      F-7
<PAGE>
                            A.D.A.M. SOFTWARE, INC.

                   NOTES TO FINANCIAL STATEMENTS (CONTINUED)

1. DESCRIPTION OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
(CONTINUED)
RESTRICTED TIME DEPOSITS

    In connection with the Company's noncancelable operating leases for its
office space and telephone system, the Company is required to purchase time
deposits to secure letters of credit with the bank guaranteeing payments under
the leases (see Note 11). The time deposits bear interest at an average rate of
approximately 5.50% and are carried at cost which approximates market. The
classification of these investments is determined based on the expected term of
the collateral requirement and not necessarily the maturity date of the
underlying securities.

INCOME TAXES

    The Company accounts for income taxes utilizing the liability method and
deferred income taxes are determined based on the estimated future tax effects
of differences between the financial reporting and income tax basis of assets
and liabilities given the provisions of the enacted tax laws. A valuation
allowance is provided against deferred tax assets for which it is more likely
than not that the asset will not be realized.

STOCK-BASED COMPENSATION

    The Company has chosen to continue to account for stock-based compensation
using the intrinsic value method prescribed in Accounting Principles Board
Opinion No. 25, "Accounting for Stock Issued to Employees," and related
Interpretations and to elect the disclosure option of SFAS No. 123, "Accounting
for Stock-Based Compensation". Accordingly, compensation cost for stock options
issued to employees is measured as the excess, if any, of the quoted market
price of the Company's stock at the date of the grant over the amount an
employee must pay to acquire the stock.

EARNINGS PER SHARE

    The computation of basic earnings per share is based on the weighted average
number of common shares outstanding during the period. The computation of
diluted earnings per share is based on the weighted average number of common
shares outstanding plus, when their effect is dilutive, potential common stock
consisting of shares subject to stock options and stock warrants. For the year
ended March 31, 1998, potential common stock shares of 43,620 have been included
in computing diluted earnings per share.

COMPREHENSIVE INCOME

    The Financial Accounting Standards Board issued Statement of Financial
Accounting Standards No. 130, "Reporting Comprehensive Income" (FAS 130), to be
effective for all fiscal years beginning after December 15, 1997. This Statement
requires that all items which are to be recognized as components of
comprehensive income be reported on a financial statement that is displayed with
the same prominence as other financial statements. The Company's comprehensive
income is the same as its net income.

RECLASSIFICATIONS

    Certain comparative amounts have been reclassified to conform with current
year presentation.

                                      F-8
<PAGE>
                            A.D.A.M. SOFTWARE, INC.

                   NOTES TO FINANCIAL STATEMENTS (CONTINUED)

2. INVESTMENT SECURITIES

    On March 31, 1999 and 1998, the Company held investment securities which it
classified as held-to-maturity. Held-to-maturity securities represent those
securities that the Company has both the positive intent and ability to hold to
maturity and are carried at amortized cost. Securities with a maturity date
within one year are classified as short-term investments and are stated at cost
plus accrued interest.

    Held-to-maturity investment securities at March 31, 1999 included the
following (in thousands):

<TABLE>
<CAPTION>
                                                                            AMORTIZED     FAIR
                                                                              COST        VALUE
                                                                           -----------  ---------
<S>                                                                        <C>          <C>
Atlantis One Funding Commercial Paper, face value of $1,000,000, interest
  at 4.672%, due April 14, 1999..........................................   $     999   $     999
General Electric Capital Corp. Commercial Paper, face value of $812,000,
  interest at 4.569%, due May 14, 1999...................................         808         808
General Electric Capital Corp. Commercial Paper, face value of
  $1,000,000, interest at 4.609%, due May 24, 1999.......................         993         993
GMAC Commercial Paper, face value of $1,000,000, interest at 4.454%, due
  June 4, 1999...........................................................         992         992
                                                                           -----------  ---------
                                                                            $   3,792   $   3,792
                                                                           -----------  ---------
                                                                           -----------  ---------
</TABLE>

    There were no realized gains or losses for the years ended March 31, 1999,
1998 and 1997.

3. INVENTORIES

    The components of inventory are summarized as follows (in thousands):

<TABLE>
<CAPTION>
                                                                                  MARCH 31,
                                                                             --------------------
<S>                                                                          <C>        <C>
                                                                               1999       1998
                                                                             ---------  ---------
Raw materials..............................................................  $     173  $     256
Finished goods.............................................................        119        211
                                                                             ---------  ---------
                                                                             $     292  $     467
                                                                             ---------  ---------
                                                                             ---------  ---------
</TABLE>

                                      F-9
<PAGE>
                            A.D.A.M. SOFTWARE, INC.

                   NOTES TO FINANCIAL STATEMENTS (CONTINUED)

4. PROPERTY AND EQUIPMENT

    Property and equipment is summarized as follows (in thousands):

<TABLE>
<CAPTION>
                                                                                  MARCH 31,
                                                                             --------------------
<S>                                                                          <C>        <C>
                                                                               1999       1998
                                                                             ---------  ---------
Computers..................................................................  $   1,364  $   1,194
Equipment..................................................................        234        299
Furniture and fixtures.....................................................        532        507
Leasehold improvements.....................................................        174        156
                                                                             ---------  ---------
                                                                                 2,304      2,156
Less--Accumulated depreciation and
  amortization.............................................................     (1,660)    (1,660)
                                                                             ---------  ---------
                                                                             $     644  $     496
                                                                             ---------  ---------
                                                                             ---------  ---------
</TABLE>

    Depreciation and amortization of property and equipment totaled
approximately $349,000, $367,000 and $457,000 for the years ended March 31,
1999, 1998 and 1997, respectively.

5. PRODUCT DEVELOPMENT EXPENDITURES

    Product development expenditures are summarized as follows (in thousands):

<TABLE>
<CAPTION>
                                                                        YEAR ENDED MARCH 31,
                                                                   -------------------------------
<S>                                                                <C>        <C>        <C>
                                                                     1999       1998       1997
                                                                   ---------  ---------  ---------
Total development expenditures...................................  $   2,182  $   2,054  $   2,761
Less: Additions to capitalized software development, prior to
  amortization...................................................       (108)      (542)      (501)
                                                                   ---------  ---------  ---------
Product development expense......................................  $   2,074  $   1,512  $   2,260
                                                                   ---------  ---------  ---------
                                                                   ---------  ---------  ---------
</TABLE>

    The activity in the capitalized software development account is summarized
as follows (in thousands):

<TABLE>
<CAPTION>
                                                                             YEAR ENDED MARCH 31,
                                                                        -------------------------------
<S>                                                                     <C>        <C>        <C>
                                                                          1999       1998       1997
                                                                        ---------  ---------  ---------
Balance at beginning of year, net.....................................  $     689  $     487  $     105
Additions, net of impairment..........................................        108        542        501
Amortization expense..................................................       (560)      (340)      (119)
                                                                        ---------  ---------  ---------
Balance at end of year, net...........................................  $     237  $     689  $     487
                                                                        ---------  ---------  ---------
                                                                        ---------  ---------  ---------
</TABLE>

    Additions, net of impairment, includes a $316,000 impairment of capitalized
software related to certain products, including some under development, that the
Company is no longer supporting.

                                      F-10
<PAGE>
                            A.D.A.M. SOFTWARE, INC.

                   NOTES TO FINANCIAL STATEMENTS (CONTINUED)

6. INCOME TAXES

    The provision for income taxes differs from the amount computed by applying
the applicable U.S. statutory federal income tax rate of 34 percent to income
(loss) before income taxes as a result of the following (in thousands):

<TABLE>
<CAPTION>
                                                                          YEAR ENDED MARCH 31,
                                                                     -------------------------------
<S>                                                                  <C>        <C>        <C>
                                                                       1999       1998       1997
                                                                     ---------  ---------  ---------
Federal tax provision (benefit) on income (loss) before income
  taxes at statutory federal income tax rate.......................  $    (741) $     222  $  (1,850)
  Change in valuation allowance....................................      1,416       (205)     2,042
  State taxes......................................................       (131)        26       (255)
  Research and development credits.................................        (77)       (37)       (38)
  Foreign taxes withheld...........................................         --         75         --
  Other............................................................       (467)        (6)       101
                                                                     ---------  ---------  ---------
                                                                     $      --  $      75  $      --
                                                                     ---------  ---------  ---------
                                                                     ---------  ---------  ---------
</TABLE>

    The components of the Company's deferred tax assets and liabilities are as
follows (in thousands):

<TABLE>
<CAPTION>
                                                                                MARCH 31,
                                                                           --------------------
<S>                                                                        <C>        <C>
                                                                             1999       1998
                                                                           ---------  ---------
Deferred tax assets
  Accrued expenses and other liabilities.................................  $     209  $     202
  Allowance for doubtful accounts........................................        126         17
  Fixed assets...........................................................        145        104
  Research and development credits.......................................        301        225
  Net operating loss carryforwards.......................................      9,127      8,118
                                                                           ---------  ---------
                                                                               9,908      8,666
                                                                           ---------  ---------
Deferred tax liabilities
  Software development costs.............................................        (90)      (264)
                                                                           ---------  ---------
                                                                                 (90)      (264)
                                                                           ---------  ---------
Net deferred tax asset before valuation allowance........................      9,818      8,402
Valuation allowance......................................................     (9,818)    (8,402)
                                                                           ---------  ---------
                                                                           $      --  $      --
                                                                           ---------  ---------
                                                                           ---------  ---------
</TABLE>

    At March 31, 1999, the Company had net operating loss and general business
credit carryforwards available for tax purposes of approximately $24,018,000 and
$301,000, respectively, which will expire in years 2012 through 2019 and 2007
through 2014, respectively. Under the Tax Reform Act of 1986, the amounts of,
and the benefit from net operating loss carryforwards may be impaired or limited
in certain circumstances, including ownership changes (as defined by the
Internal Revenue Service). At March 31, 1999 and 1998, the Company has recorded
a valuation allowance equal to its net deferred tax assets as management
believes it is more likely than not that the net deferred tax assets will not be
realized. Management's estimate of the valuation allowance could be affected in
the near term based on taxable income generated in future periods.

                                      F-11
<PAGE>
                            A.D.A.M. SOFTWARE, INC.

                   NOTES TO FINANCIAL STATEMENTS (CONTINUED)

7. TREASURY STOCK

    In April 1997, the Company's Board of Directors adopted a stock repurchase
program. The program authorized repurchase of the Company's common stock from
time to time in open market transactions on the Nasdaq Stock market. During
fiscal years 1999 and 1998, the Company repurchased common stock at various
times with an aggregate cost of approximately $766,000 and $1,420,000,
respectively. The Company used cash on hand to fund the repurchase program. The
repurchased stock is held as treasury stock.

8. COMMON STOCK OPTIONS AND WARRANTS

    The Company has two stock option plans (the 1992 Option Plan and the 1991
Option Plan) under which the Company may grant incentive or non-qualified stock
options to full-time employees and key persons. Options are granted at an
exercise price as determined by the Company's Board of Directors which is not
less than fair market value of the Company's common stock and vest ratably over
a three-year period. Options granted under the 1992 Option Plan expire ten years
from the date of grant. With respect to the 1991 Option Plan, all options
granted under the plan were exercised or expired. No further grants under the
1991 Option Plan are authorized.

    In addition to the options granted under the 1992 and 1991 Option Plans, the
Company has granted options to purchase shares of its common stock to certain
employees, directors and consultants in connection with their association with
the Company. These options vest from immediate to ratably over three years and
have terms from five to ten years. The Company has reserved 1,400,000 shares of
common stock for issuance under the 1992 Option Plan.

    Additionally, there are 214,063 warrants outstanding with an exercise price
of $8.00 per share related to various debt and equity financing of the Company
which occurred prior to fiscal 1997. The warrants are fully vested and
exercisable, and they expire in fiscal 2000 and 2001.

    The Company has adopted the disclosure only provisions of SFAS No. 123,
"Accounting for Stock-Based Compensation ("SFAS 123")". Accordingly, no
compensation cost has been recognized for options issued to employees under the
Company's stock option plans. Had compensation cost for the Company's stock
option grants been determined based on the fair value at the grant date for
awards in fiscal 1999, 1998 and 1997 consistent with the provisions of SFAS 123,
the Company's net income (loss) and net income (loss) per share would have been
changed to the pro forma amounts indicated below (in thousands, except per share
amounts):

<TABLE>
<CAPTION>
                                                                     1999       1998       1997
                                                                   ---------  ---------  ---------
<S>                                                                <C>        <C>        <C>
Net income (loss)
    As reported..................................................  $  (2,180) $     578  $  (5,441)
    Pro forma....................................................     (2,560)       380     (5,566)
Basic and diluted net income (loss) per share
    As reported..................................................  $   (0.48) $     .12  $   (1.03)
    Pro forma....................................................      (0.57)       .07      (1.05)
</TABLE>

    The fair value of each option grant is estimated on the date of grant using
the Black-Scholes option-pricing model with the following weighted-average
assumptions used for grants in fiscal 1999, 1998 and 1997, respectively:
dividend yield of 0% for all years; expected volatility of 70% for 1999 and 56%
for 1998 and 1997; average risk-free interest rates of 4.94%, 6.01% and 6.22%;
and expected life

                                      F-12
<PAGE>
                            A.D.A.M. SOFTWARE, INC.

                   NOTES TO FINANCIAL STATEMENTS (CONTINUED)

8. COMMON STOCK OPTIONS AND WARRANTS (CONTINUED)
of 3.5 years for all options with the exception of options granted in fiscal
year 1999 with one year vesting periods, which have an expected life of two
years.

    The following table summarizes stock option activity for the three years
ended March 31, 1999:

<TABLE>
<CAPTION>
                                                                          WEIGHTED     WEIGHTED
                                                            EXERCISE       AVERAGE      AVERAGE
                                                              PRICE       EXERCISE       FAIR
                                                SHARES      PER SHARE       PRICE        VALUE
                                              ----------  -------------  -----------  -----------
<S>                                           <C>         <C>            <C>          <C>
Outstanding at March 31, 1996...............   1,129,735   $2.00-12.00    $    6.20
  Granted...................................      83,400     2.25-2.50         2.41    $    1.18
  Exercised.................................     (40,000)    2.00-3.00         2.41
  Canceled or expired.......................    (520,108)   2.38-11.11         6.69
                                              ----------
Outstanding at March 31, 1997...............     653,027    2.25-12.00         6.06
  Granted...................................     515,600    2.00-10.00         4.96         0.95
  Exercised.................................          --            --           --
  Canceled or expired.......................    (214,893)   2.00-11.11         5.10
                                              ----------
Outstanding at March 31, 1998...............     953,734    2.00-12.00         5.73
  Granted...................................     706,000     2.75-5.25         4.15         2.02
  Exercised.................................     (11,100)    2.00-2.38         2.04
  Canceled or expired.......................    (550,434)   2.00-11.11         5.60
                                              ----------
Outstanding at March 31, 1999...............   1,098,200    2.00-12.00         5.37
                                              ----------
                                              ----------
Options exercisable at March 31, 1999.......     351,711
                                              ----------
                                              ----------
</TABLE>

    The following table summarizes additional information about stock options
outstanding at March 31, 1999:

<TABLE>
<CAPTION>
                             OPTIONS OUTSTANDING               OPTIONS EXERCISABLE
                  -----------------------------------------  ------------------------
<S>               <C>          <C>              <C>          <C>          <C>
                                  WEIGHTED
                                   AVERAGE       WEIGHTED                  WEIGHTED
                    NUMBER        REMAINING       AVERAGE      NUMBER       AVERAGE
    RANGE OF      OUTSTANDING    CONTRACTUAL     EXERCISE    EXERCISABLE   EXERCISE
 EXERCISE PRICE   AT 3/31/99        LIFE           PRICE     AT 3/31/99      PRICE
----------------  -----------  ---------------  -----------  -----------  -----------
$2.00 to 2.94        251,100           6.81      $    2.30      132,011    $    2.31
$3.25 to 4.75        146,400           9.06           3.60        3,200         4.75
$5.00 to 5.25        607,400           8.77           5.20      123,200         5.00
$7.00 to 12.00        93,300           4.64           7.63       93,300         7.63
                  -----------                                -----------
                   1,098,200           8.04      $    4.50      351,711    $    4.58
                  -----------                                -----------
                  -----------                                -----------
</TABLE>

    In April 1997, the Company granted non-qualified stock options to two
officers of the Company to acquire 120,000 shares each of the Company's common
stock. The vesting period for 60,000 of the options granted to each officer is
one-third per year for three years. The vesting period of the remaining 60,000
options granted to each officer is one-third per year for three years or, if the
Company's stock price reaches certain targets, vesting will occur in blocks of
20,000 options for each target price met. The exercise price for the first
20,000 options granted to each officer is $5.00 per share. The exercise price
for the remaining options increases by $1.00 for each block of 20,000 options.

                                      F-13
<PAGE>
                            A.D.A.M. SOFTWARE, INC.

                   NOTES TO FINANCIAL STATEMENTS (CONTINUED)

8. COMMON STOCK OPTIONS AND WARRANTS (CONTINUED)
    In January 1999, the Company provided employee holders of options with
exercise prices from $3.50 and higher the opportunity to modify the exercise
price of the options to the then current market price of $5.25. As a result of
this election, 423,400 options were canceled and reissued in January 1999 with a
vesting period of one year. The new option exercise price equals the market
price on the date of the repricing and, correspondingly, compensation expense
was not recognized.

9. EMPLOYEE BENEFIT PLAN

    The Company sponsors a defined contribution plan that provides all permanent
employees of the Company an opportunity to accumulate funds for their
retirement. In January 1999, the Company began to match the contributions of
participating employees to the extent of 50% of the first 6% contributed by the
participant. Company matching contributions to the plan were approximately
$17,000 in fiscal 1999.

10. RELATED PARTY TRANSACTIONS

    During fiscal 1999, 1998 and 1997, the Company sold approximately $353,000,
$17,000 and $11,000, respectively, of product to Addison Wesley Longman, Inc., a
shareholder in the Company. During fiscal 1999, 1998 and 1997, the Company sold
approximately $0, $42,000 and $0, respectively, of product to Benjamin/Cummings
(BC), a subsidiary of a shareholder of the Company. The Company earned royalty
revenues of approximately $248,000, $217,000 and $134,000, related to BC during
fiscal 1999, 1998, and 1997, respectively. Additionally, the Company purchased
approximately $6,000, $43,000 and $22,000 of product from BC during fiscal 1999,
1998 and 1997, respectively, and paid royalty expenses to BC of approximately
$217,000, $215,000 and $70,000, respectively.

    During fiscal 1997, J.S.K., Inc. (JSK), whose president is a director and
shareholder of the Company, paid the Company approximately $68,000 in licensing
and rental fees.

    There were 78,438 warrants outstanding during fiscal 1999, 1998 and 1997,
related to various debt and equity financing that were held by an officer and
shareholder (directly and indirectly).

11. COMMITMENTS AND CONTINGENCIES

    The Company leases office space and equipment under noncancelable lease
agreements expiring on various dates through 2002. In February 1999, the Company
entered into a noncancelable agreement to sublease a portion of its office
space. At March 31, 1999, future minimum rentals, net of sublease rental income,
for noncancelable leases with terms in excess of one year were as follows (in
thousands):

<TABLE>
<CAPTION>
                                                                 MINIMUM     SUBLEASE        NET
                         YEAR ENDING                             ANNUAL       ANNUAL       MINIMUM
                          MARCH 31                               RENTALS      RENTALS      RENTALS
                   ----------------------                      -----------  -----------  -----------
<S>                                                            <C>          <C>          <C>
2000.........................................................   $     522    $     (70)   $     452
2001.........................................................         522          (70)         452
2002.........................................................         522          (18)         504
2003.........................................................         175           --          175
                                                               -----------  -----------  -----------
                                                                $   1,741    $    (158)   $   1,583
                                                               -----------  -----------  -----------
                                                               -----------  -----------  -----------
</TABLE>

    Rent expense for the years ended March 31, 1999, 1998 and 1997 was
approximately $403,000, $417,000 and $640,000, respectively.

                                      F-14
<PAGE>
                            A.D.A.M. SOFTWARE, INC.

                   NOTES TO FINANCIAL STATEMENTS (CONTINUED)

11. COMMITMENTS AND CONTINGENCIES (CONTINUED)
    On April 25, 1996 the Company and certain of its officers and directors were
named in a shareholders' class action lawsuit. The complaint alleges violations
of Section 11, 12(2) and 15 of the Securities Act of 1933, violations of the
Georgia Securities Act and negligent misrepresentation arising out of alleged
disclosure deficiencies in connection with the Company's initial public offering
which was completed on November 10, 1995. The complaint seeks compensatory
damages and reimbursements for plaintiff's fees and expenses. The Company and
its officers and directors are vigorously defending against the allegations. The
Company cannot estimate the impact of the outcome of the lawsuit on the
financial condition or results of operations.

    The Company is subject to other legal proceedings and claims which have
arisen in the ordinary course of its business. Management believes, based upon
the advice of counsel, that ultimate resolution of these matters will not have a
material adverse effect on the financial statements taken as a whole.

12. SEGMENT INFORMATION

    During June 1997, the Financial Accounting Standards Board issued Financial
Accounting Standard No. 131, "Disclosures about Segments of an Enterprise and
Related Information" (FAS 131). The statement requires detailed disclosures
surrounding operating segments and certain enterprise-wide disclosures.
Management believes that it has only a single operating segment that is focused
on the development and distribution of anatomy/medical content. The
enterprise-wide disclosures required by FAS 131 are presented in the tables
below (in thousands):

<TABLE>
<CAPTION>
                                                                        YEAR ENDED MARCH 31,
                                                                   -------------------------------
<S>                                                                <C>        <C>        <C>
                                                                     1999       1998       1997
                                                                   ---------  ---------  ---------
REVENUES BY MARKET
Education........................................................  $   4,068  $   5,357  $   2,523
Consumer.........................................................        289        652      1,978
Professional.....................................................        695        821         --
Other............................................................       190`         58         90
                                                                   ---------  ---------  ---------
                                                                   $   5,242  $   6,888  $   4,591
                                                                   ---------  ---------  ---------
                                                                   ---------  ---------  ---------
</TABLE>

    The Company exports its products through agreements with international and
domestic distributors which grant territorial rights. During the years ended
March 31, 1999, 1998 and 1997, the Company had net revenue from international
sales of approximately $355,000, $1,643,000 and $709,000, respectively. A
summary of revenues by geographic area is as follows (in thousands):

<TABLE>
<CAPTION>
                                                                        YEAR ENDED MARCH 31,
                                                                   -------------------------------
<S>                                                                <C>        <C>        <C>
                                                                     1999       1998       1997
                                                                   ---------  ---------  ---------
United States....................................................  $   4,887  $   5,245  $   3,882
Europe...........................................................        150        371        474
Pacific Rim and Asia.............................................         56      1,003        119
Other............................................................        149        269        116
                                                                   ---------  ---------  ---------
                                                                   $   5,242  $   6,888  $   4,591
                                                                   ---------  ---------  ---------
                                                                   ---------  ---------  ---------
</TABLE>

    No geographic region within Europe accounted for more than 10% of total
sales during the three-year period ended March 31, 1999.

                                      F-15
<PAGE>
                            A.D.A.M. SOFTWARE, INC.

                   NOTES TO FINANCIAL STATEMENTS (CONTINUED)

12. SEGMENT INFORMATION (CONTINUED)
    Two customers accounted for approximately 11.5% and 11.1% of net sales in
fiscal 1999. For the year ended March 31, 1998 and 1997, the Company had sales
to single customers which totaled 10.9% and 16% of net revenues, respectively.

13. RESTRUCTURING

    During the second quarter of fiscal 1997, the Company implemented a
restructuring plan (the 1997 Plan) designed to enhance overall competitiveness,
productivity and efficiency through the reduction of overhead costs. The 1997
Plan resulted in a pre-tax charge of approximately $490,000. The charge
principally reflects severance costs resulting from realignments throughout the
Company, including workforce reductions of 29 employees, employee termination
costs and costs associated with non-cancelable leases net of estimated sublease
rental income. Total payments of approximately $445,000, primarily related to
severance agreements were made subsequent to the implementation of the 1997
Plan. The remaining accrued restructuring costs relate to the fair value of
stock options issued as part of the 1997 Plan.

    During the fourth quarter of fiscal 1999, the Company implemented a plan to
release substantially all of its direct sales force. This restructuring plan
resulted in a pre-tax charge of approximately $47,000 relating to the severance
costs for the employees terminated. As of March 31, 1999, no payments have been
made. During April 1999, additional employees were terminated with a severance
cost of approximately $35,000.

14. SUBSEQUENT EVENTS

    The Company has received approximately $477,000 of proceeds as a result of
75,100 shares of common stock issued pursuant to exercisable stock options.

    In May 1999, the Company paid $50,000 in cash to enter into a license
agreement with a pediatric health information website (Dr.Green.com) and expects
to purchase the Company that operates the website for 80,000 shares of the
Company's stock during fiscal 2000.

UNAUDITED

    In April 1999, the Company paid $250,000 for a 40% interest in ThePort.com,
an internet software development entity. The Company's chief executive officer
also acquired a 20% interest in the venture.

                                      F-16